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ABSTRACT
Tinnitus is a phantom sensation of sounds in the absence of external acoustic
stimuli. This hearing abnormality can be caused by ototoxic drugs such as sodium
salicylate (SS) and lead to emotional responses such as stress. It is likely that tinnitus is
caused by a change in the activity in the central nervous system, which is dependent on
excitatory/inhibitory neurotransmission. Gamma-aminobutryic acid (GABA) is the main
inhibitory neurotransmitter in the brain that activates type-B GABAergic (GABAB
receptors), which in turn can regulate the excitation/inhibition throughout the nervous
system. I hypothesize that there will be a change in the GABAB receptors in the rat’s
nervous system, specifically in the limbic system which is responsible for emotion and
stress. Immunohistochemistry results indicate an increase in the level of GABAB
receptors after SS exposure. Tinnitus is commonly understood to cause an increase in
activity in the central nervous system. An increase in GABAB receptors can be indicative
of an increase in pre-synaptic GABAB receptors, which regulate the release the GABA.
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1. Introduction
1.1 Hearing and hearing abnormalities
Hearing is the ability of an organism to sense and perceive sound vibrations. It is
one of the five basic senses (Carlson, 2001). Hearing is important for the biological
fitness of animals, including humans. It is required by many animal behaviours such as
mating and social communication. Hearing is not only dependent on the ears but also
dependent on a group of brain structures collectively called the central auditory system
(Pickles, 2012).
Structural, neurochemical, and neurophysiological changes in the ear and/or the
central auditory system can lead to hearing abnormalities, such as deafness, hyperacusis,
and tinnitus. While hyperacusis is heightened sensitivity to sound, tinnitus is phantom
sensation of sound in the absence of external acoustic stimulation (See section 1.7 for
details).
Recent studies indicate that auditory neural processing centers receive inputs from
other brain regions such as limbic structures (Kraus and Canlon, 2012). In individuals
with tinnitus, the neural activity increases in limbic structures. Due to the neural
connectivity, changes in the inputs from these structures can affect neural responses in
the auditory system, which can also lead to hearing abnormalities (Kraus and Canlon,
2012; Chen et al., 2014).
1.2 The auditory periphery
The peripheral auditory system, i.e., the ear, consists of the outer, middle, and
inner ears. The outer ear consists of the pinna and the ear canal. The middle ear contains
three oscicles, i.e., the malleus, incus, and stapes. The inner ear contains the cochlea, a

1

spiral-shaped structure that has the appearance of a coiled snail’s shell (Silverthorn, 2007;
The peripheral auditory system, 2016).
The cochlea has a hard bony shell encompassing a membranous system. The
membrane important for sensory transduction, i.e., the conversion of mechanical
vibrations into electrical neural signals, is called the basilar membrane. The basilar
membrane separates the fluid-filled interior of the cochlea into two major parts. The
lower part is called the scala tympani and is filled with perilymph, which is low in K+
concentration and high in Na+ concentration (Johnstone and Sellick, 1972; The peripheral
auditory system, 2016). The upper part is further divided by the Reissner’s membrane
into two compartments. The top compartment is known as the scala vestibule, which
contains perilymph in similar concentration to the scala tympani. The other compartment
is known as the scala media, which contains endolymph that is high in K+ concentration
and low in Na+ concentration (Bosher and Warren, 1968).
The Organ of Corti is an auditory sensory organ that is found in the basilar
membrane. It has two types of mechanoreceptor cells: inner hair cells (IHCs) and outer
hair cells (OHCs). These mechanoreceptors have stereocilia on their apical surfaces. The
stereocilia are connected to one another by tip-links. When a sound reaches the ear, it
eventually vibrates the basilar membrane and an overlaying membrane named tectorial
membrane. The relative movements between the two membranes cause the stereocilia of
hair cells to bend and mechanical force-gated ion channels attached to the tip-links to
open. K+ ions then flux from the endolymph into a hair cell, causing depolarization of the
cell (Hudspeth, 1982; The peripheral auditory system, 2016). In this way, mechanical
signals are transduced (i.e., converted) into electrical signals, which can be sent through
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the cochlear nerve to the central auditory system (CAS) for processing (Silverthron,
2007).
1.3 The central auditory system (CAS): Major structures and interconnections
There are six major structures in the central nervous system with primary
functions related to hearing. These structures include the cochlear nucleus (CN), superior
olivary complex (SOC), nucleus of lateral lemniscus (NLL), inferior colliculus (IC),
medial geniculate nucleus (MGN), and the auditory cortex (AC). These six major
auditory structures form an ascending pathway, with CN at the bottom receiving auditory
signals from the cochlea in the inner ear and the AC at the top of the hierarchy. Such a
hierarchy has been conserved in mammals throughout evolution and thus a homology to
humans exists (Figure 1).
1.3.1 Ascending auditory pathway
1.3.1.1 Cochlear nucleus (CN)
The first brainstem auditory structure along the ascending pathway is the CN
(Figure 2). It consists of two major subdivisions, the dorsal CN (DCN) and the ventral
CN (VCN). The VCN can be further subdivided into the anterior VCN (AVCN) and
posterior VCN (PVCN) (Malmierca and Merchan, 2005). The CN receives direct inputs
from the peripheral auditory system through the auditory nerve (i.e., the 8th cranial
nerve). It sends projections to the SOC, NLL, IC, and MGN (Schofield and Coomes,
2005). There are different cell types in each subdivision of the CN. These cells have
different cell morphology and temporal patterns of action potential discharge in response
to acoustic stimulation. For instance, globular and spherical bushy cells in the AVCN fire
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Figure 1: Visual representation of the ascending and descending projections in the
nervous system a human and rat brain. (A) Visual representation of the ascending
projections found in the human brain (left) and the rat brain (right). (B) descending
projections found in the human brain (left) and the rat brain (right). [Courtesy of Dina
Kokh].
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over the whole duration of a stimulus. Octopus cells found in the PVCN only fire at the
onset of a stimulus. Fusiform and pyramidal cells in the DCN fire at the offset of a
stimulus (Gil-Layzaga et al., 2013). The CN is involved in analyzing the intensity,
duration, and on- and offset of an acoustic stimulus (Gil-Layzaga et al., 2013).
1.3.1.2 Superior olivary complex (SOC)
The SOC is the second brainstem structure along the ascending auditory pathway
(Figure 2). The SOC is composed of six small subdivisions (Malmierca and Merchan,
2005). These subdivisions include the lateral nucleus of the trapezoidal body (LNTB), the
ventral nucleus of trapezoidal body (VNTB), the medial nucleus of the trapezoidal body
(MNTB), the lateral superior olivary nucleus (LSO), the medial superior olivary nucleus
(MSO), and the superior paraolivary nucleus (SPN). SOC receives inputs from the CN
and sends projections to the NLL and IC (van Adel and Kelly, 1998). Major functions of
the SOC are related to the localization of sounds (van Adel and Kelly, 1998). Two of the
major subdivisions, the MSO and LSO, are especially important for these functions.
While the MSO is critical for localizing sounds by using interaural-time difference (ITD)
cues, the LSO is essential for localizing sounds by using interaural-level difference (ILD)
cues (Tollin, 2003). Other functions of the SOC are related to the suppression of echoes
of sounds from the environment (Malmierca and Merchan, 2005).
1.3.1.3 Nucleus of the lateral lemniscus (NLL)
The NLL is the last brainstem structure along the ascending auditory pathway
(Figure 2). This structure consists of two different groups of neurons associated with two
different innervation patterns. Neurons in the ventral NLL (VNLL) receive inputs driven
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Figure 2: Schematic diagram showing the major ascending projections in the central
auditory structures. Abbreviations: AC: auditory cortex, MG: medial geniculate body,
IC: inferior colliculus, NLL: nucleus of lateral lemniscus, SOC: superior olivary
complex, CN: cochlear nucleus [Modified from Winer and Schreiner, 2005].
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by only the ear on the contralateral side. These monaural neurons are involved in
processing temporal characteristics of sounds (Gil-Layzaga et al., 2013). Neurons in the
dorsal NLL (DNLL) receive diverse inputs, with some of them driven by the contralateral
ear while others diven by both ears. Neurons in the DNLL are involved in sound
localization (Aitkin et al., 1970; Bruggae et al., 1970, Bajo et al., 1998; Gil-Layzaga et
al., 2013).
1.3.1.4 Inferior Colliculus (IC)
The IC is a midbrain auditory structure (Figure 2). It receives projections from all
the major brainstem structures (CN, SOC, and NLL) and forebrain structures (MGN and
AC, see section 1.3.1.5 and 1.3.1.6). The IC is the primary source of projections for the
MGN, which relays auditory information to the AC (Malmierca and Merchan, 2005). The
IC includes three subdivisions: the central nucleus of the IC (ICc), the dorsal cortex of the
IC (ICd), and the external cortex of the IC (ICx). Neurons in the ICc are organized in
such a way, that neurons sensitive to low frequencies are located in the dorsolateral parts
while neurons sensitive to high frequencies are located in the ventromedial part of the
structure. This topographic organization (i.e., tonotopic organization) allows for
processing of frequency information of sound. Among other acoustic characteristics
processed by the ICc are the ITD and ILD. The involvement of this collicular subdivision
in processing these aboustic characteristics suggests that it contributes to the localization
of sounds (Gil-Layzaga et al., 2013). The ICd and ICx are involved in processing higher
order information, such as language and identifying novel sounds.
1.3.1.5 Medial geniculate nucleus (MGN)
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The MGN is a thalamic structure and it is the only structure that sends direct
projections to the AC (Figure 2). The MGN, along with the AC, is a forebrain auditory
structure. The MGN can be subdivided into the ventral division of the MGN (MGv), the
dorsal division of the MGN (MGd), and medial division of the MGN (MGm).
The MGv
The MGv receives major projections from the contralateral ICc and ipsilateral
ICc, ICd, and ICx (Bordi and LeDoux, 1994; Gonzalez-Hernandez et al., 1991;
Malmierca and Merchan, 2005). It sends projections to the AC as well as the IC (Winer
and Schreiner, 2005). The MGv is involved in the processing of basic characteristics of
sounds including temporal structures and frequency content (Bordi and LeDoux, 1994).
The MGd
The MGd receives projections from the ICd, ICx, and somatosensory system
(Winer, 1985). It sends projections to the ICx and secondary AC areas (Winer, 1992;
Malmiera and Merchan, 2004). The main function of the MGd is most likely related to
the processing of complex sounds, including the recognition of sound patterns (Bordi and
LeDoux, 1994).
The MGm
The MGm is a small subdivision receiving projections from many structures. It
provides outputs to a variety of other structures. Auditory input projections include those
from the ICx, ICd, CN, SOC, VNLL, and the reticular thalamic nucleus (Winer, 2005).
The MGm communicates with structures outside the major auditory pathway, which
include the somatosensory cortex (Spreafico et al., 1981), visual system (Malmierca et
al., 2002), and the amygdala (Otterson and Ben-Ari, 1979; Otterson, 1981; LeDoux,
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1985, 1987). The complex connections render the MGNm a variety of functions. It is
believed that the structure is involved in multisensory integration (Bordi and LeDoux,
1994) and processing of emotional characteristics of sounds (LeDoux et al., 1984).
1.3.1.6 Auditory Cortex (AC)
The AC is a part of the temporal cortex. Along with the MGN, the AC is a key
forebrain auditory center (Figure 2). It can be subdivided into the primary auditory cortex
(A1), the secondary auditory cortex (A2), and association auditory cortices. The A1 is
sometimes also referred to as the core area of the auditory cortex, while the other areas
are sometimes also referred to as the belt areas (Gil-Layzaga et al., 2013). The AC can be
subdivided into six layers. From the surface to the deep part of the structures are layers I
through VI (Gil-Layzaga et al., 2013). The AC plays a critical role in the sensation,
perception, and cognition of sounds (Gaese and Ostwald, 1995). Neurons in the A1 are
arranged topographically based on frequency that they best respond to. The ones that
respond best to low frequencies correspond to the apex of the cochlea and the ones that
respond best to high frequencies correspond to the base of the cochlea. Such a tonotopic
organization is important for the processing of frequency information of sounds. The belt
areas of the AC do not have tonotopic organizations. Neurons in this subarea are involved
in sound localization, auditory memory, and understanding complex sounds such as
language. Neurons in the belt regions also contributes to the integration of auditory
information with other sensory systems (Gil-Layzaga et al., 2013).
1.3.2 Descending and commissural projections in the central auditory system
Major auditory structures not only provide ascending projections to higher
structures in the hierarchy of the auditory system, they also provide descending
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Figure 3: Schematic diagram showing the major descending projections in the
central auditory system. Abbreviations: AC: auditory cortex, MG: medial geniculate
body, IC: inferior colliculus, NLL: nucleus of lateral lemniscus, SOC: superior olivary
complex, CN: cochlear nucleus [Modified from Winer and Schreiner, 2005].
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projections to lower structures and commissural projections to the contralateral side of
the brain (Figure 3).
1.3.2.1 Major structures providing descending projections
1.3.2.1.1 Auditory cortex (AC)
Being at the very top of the hierarchal auditory pathway, the auditory cortex sends
many descending projections to other structures. Neurons from both layer V and VI send
ipsilateral projections to the MGNv and MGNd (Winer and Prieto, 2001). Neurons in the
layer V of the AC also send descending projections to the IC (Schofield, 2009). These
cortico-collicluar connections are of critical importance for auditory processing.
Projections from the AC are also sent to the CN (Schofield and Coomes, 2005).
1.3.2.1.2 Medial geniculate nucleus (MGN)
The MGN does not send many descending projections. However, there are some
ipsilateral projections to the IC. Specifically, these projections are sent to the ICx
subdivision of the IC (Malmierca et al., 1999).
1.3.2.1.3 Inferior colliculus (IC)
The IC sends descending projections to the CN (Schofield and Coomes, 2005). It
can send projections further downward to the periolivary medial olivocochlear cells,
which are cells that innervate the OHCs (Faye-lund, 1986; Caicedo and Herbert, 1993;
Saldana, 1993; Vetter et al., 1993).
1.3.2.1.4 Nucleus of lateral lemniscus (NLL)
The NLL is a small structure that does not have many descending projections. The
CN is the only one auditory structure that receives descending projections from the NLL
(Schofield and Coomes, 2005).
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1.3.2.1.5 Superior olivary complex (SOC)
The only central target structure of descending projections from the SOC is the
CN (Schofield and Coomes, 2005). Descending neural projections from the SOC are also
sent to the cochlea of the inner ear. These projections provide protection to sensory
receptor cells in the cochlea. When these cochlear cells are exposed to a loud sound
(>80dB), the descending projections from the SOC provide signals to cause middle ear
muscles to contract and the basilar membrane to become rigid, thereby reducing the
movement of the basilar membrane and decreasing the energy being provided to the inner
ear (Gil-Layzaga et al., 2013).
1.3.2.1.6 Cochlear nucleus (CN)
The CN is at the very bottom of the hierarchy. Due to this, it does not provide any
descending projections to other central auditory structures. However, it is one of
structures that receive many descending projections. It receives projections from the AC,
IC, and SOC (Schofield and Coomes, 2005).
1.3.2.2 Major commissural projections
Commissural projections exist throughout the CNS. These are projections that
connect structures from both sides by crossing the midline (Gonzalez-Hernandez et al.,
1986; Saldana and Merchan, 1992). The mammalian forebrain consists of two main
cortical hemispheres. Interconnections exist between the two due to major white matter
tracts, known as the corpus callosum (Robichaux et al., 2016). There exists commissure
of Probst that are found between the DNLL of both sides and also from the DNLL to the
ICc. Binaural responses in DNLL are mostly influenced by these projections (Beyerl,
1978; Adams, 1979; Zook and Casseday, 1982; Bajo et al., 1993; Merchan et al., 1994).
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There also exist commissure projections between the two IC structures on both sides of
the brain. These are known as the commissure of the inferior colliculus and include many
excitatory fibres and some inhibitory fibres(Hernandez et al., 2006).
1.4 The limbic system and its relation with the auditory system
The auditory system is regulated by other systems in the brain. Such regulation
aids in hearing (Galazyuk et al., 2012; Kraus and Canlon, 2012). The systems involved in
the regulation of auditory functions include the limbic system (Figure 4). Existing
evidence indicate that major limbic structures including the amygdala and hippocampus
either directly or indirectly innervate auditory structures including the MG and IC
(Moller and Rollins, 2001; Kraus and Canlon, 2012). The projections to the MG are
likely involved in the gating of auditory signals relayed from the MG to the AC (Muhlau
et al., 2006; Rauschecker et al., 2010). The MGN sends direct projections to the
amygdala, which innervates the hippocampus. The hippocampus sends direct projections
to the amygdala, which innervates the IC (Kraus and Canlon, 2012). The reciprocal
innervations between the auditory and limbic system provide structural bases of limbic
regulation of hearing.
1.4.1 Amygdala
The amygdala is an almond-shaped structure found in the temporal lobe of the
brain. The structure is well known for its role in emotions such as stress (Sah et al.,
2003). Besides, the structure is involved in the processing of information related to all
major sensory modalities including audition, olfaction, somatosensation, gustation, and
vision (Sah et al., 2003). The amygdala can be subdivided into four subdivisions (Figure
5): the lateral nucleus (LaN), central nucleus (CeN), basolateral nucleus (BLN), and
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Figure 4: Neural connectivity between auditory and limbic systems. Green: represents
the auditory structures. Purple: represents the amygdala. Blue: represents the
hippocampus. [Kraus and Canlon, 2012]
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Figure 5: Major subdivisions in the amygdala. Blue: represents the lateral and
basolateral subdivisions. Green: represents the central and basomedial subdivisions. [Sah
et al., 2003]
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basomedial nucleus (BMN) of the amygdala (Le Doux, 2007). These subdivisions differ
in cytoarchitectonics and connectivity (Krettek and Price, 1978; Pitkanen, 2000).
Basolateral Amygdala (BLA)
The BLA, sometimes referred to as the basal amygdala, receives major
projections form the subicular regions of the hippocampus (see below). Among all the
amygdaloid subnuclei, the BLA is the main target for fiber projections from the
hippocampus (Canteras and Swanson, 1992). The BLA sends projections to the
hippocampus, prefrontal cortex, nucleus accumbens, and the thalamus (Pare et al., 1995).
The cells of the BLA have been well defined based on Golgi impregnation
staining. Almost 70% of the cells in the BLA are pyramidal cells (Hall, 1972; Millhouse
and DeOlmos, 1983; Washburn and Moises, 1992). These pyramidal neurons have
randomly oriented apical dendrites (McDonald, 1992; Rainnie et al., 1993; Pare et al.,
1995; Faber et al., 2001). The second types of cells found in the BLA look like the
nonspiny stellate cells found in the neocortex (Hall, 1972). Other cells found in the BLA
include the extended neurons, cone cells, chandelier cells, and neurogliaform cells
(Faulkner and Brown, 1999; Kamal and Tombol, 1975; McDonald, 1982).
Lateral nucleus of the amygdala (LaN)
The LaN serves as a point of entry of the amygdala. Most of the structures
innervating the amygdala contact the LaN, which relays neural signals to the other
subdivisions of the amygdala (Sah et al., 2003). The LaN receives inputs from MGN
(LeDoux et al., 1990; LeDoux et al., 1991; Turner and Herkenham, 1991). Retrograde
tract-tracing studies revealed no direct projections from the Te1 to the amygdala
(Mascagni et al., 1993; Shi and Cassell, 2001). However, projections from other cortical
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regions such as Te3 to the LaN do exist (LeDoux et al., 1991; Shi and Cassell, 2001). In
addition to these connections with forebrain auditory structures, the LaN has connections
with brain areas responsible for long-term memory. These areas include the perirhinal
cortex, entorhinal cortex, parahippocampal cortex, and the hippocampus (Macdonald,
1998; Milner et al., 1998; Pitkanen et al., 2000).
The cell types found in the LaN are quite similar to those found in the BLA.
Generally, cells in the LaN are smaller than those in the BLA. The cells in the LaN have
an average soma size of 10-15µm, whereas the cells in the BLA have an average soma
size of 15-20µm (McDonald, 1982; Millhouse and DeOlmos, 1983).
Basomedial amygdala (BMA)
The BMA receives fiber innervations from the LaN and BLA (Sah et al., 2003). It
sends fiber outputs to the CeN, which acts as the output station and relays neural signals
to other structures in various regions of the CNS, including the auditory system (Pitkanen
et al., 1997).
There is only one known cell type in the BMA. These cells have relatively small
or medium sizes and ovoid shapes. Most neurons have two to four spiny primary
dendrites in this structure (McDonald, 1992).
Central nucleus of the amygdala (CeN)
The CeN sends projections to many target structures that are responsible for
various different functions. Among these targets, the hypothalamic nucleus is involved in
the activation of the autonomic system (Kapp et al., 1982; LeDoux et al., 1988). Other
target structures include the periaqueductal gray, which can modify vocal and
cardiovascular functions (Behbehani, 1995; Rizvi et al., 1991). The parabrachial nucleus
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Figure 6: Major subdivisions in the hippocampus. (A) shows a rostral slice of the
hippocampus. Major subdivisions are colour coordinated with the legend at the bottom.
(B) shows a caudal slice of the hippocampus. Major subdivisions are colour coordinated
with the legend at the bottom. [Modified from Kjonigsen et al., 2011]
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is involved in pain processing (Gauriau and Bernard, 2002; Moga and Gray, 1985). In
addition, the CeN also send fiber projections to the stria terminalis (Dong et al., 2001)
and nuclei in the midbrain, pons, and medulla (Veening et al., 1984).
There are three different cell populations in the CeN. The predominant cell type is
known as the medium spiny neurons (McDonald, 1982; Hall, 1972). Another type has
larger soma than the medium spiny neurons and a thick aspiny dendrite (Schiess et al.,
1999; Cassell and Gray, 1989). The third type of neurons are aspiny neurons. They exist
throughout the CeN but are small in number (Cassell and Gray, 1989). The three types of
cells exist homogenously throughout the CeN (Sah et al., 2003).
1.4.2 Hippocampus
The major function of the hippocampus is related to the formation of memory
(Tulving and Markowitsch, 1998), although the structure is also involved in other high
functions such as stress (McEwen, 1999).
The structure receives projections from other structures. One of these other
structures is the amygdala, which sends many projections to the different subdivisons of
the hippocampus (Ottersen, 1982; Kishi et al., 2006; Cenquizca and Swanson, 2007).
Target structures of projections from the hippocampus include olfactory bulb
(Cenquizca and Swanson, 2007), primary visual cortex (Miller and Vogt, 1984),
entorhinal cortex (Burwell and Amaral, 1998), and hippocampal formation (Verwer et al.,
1997). Major subdivisions of the hippocampus include the cornus ammonis 1-3 (CA1CA3), dentate gyrus (DG), and subicular area (SUB) (Figure 6) (O’Mara, 2005; Amaral
et al., 2007; Mohedano-Moriano et al., 2007). The CA1-CA3 and the DG are collectively
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called the hippocampus proper, while the SUB is sometimes also referred to as the
hippocampal formation.
Cornus ammonis 1 (CA1)
The CA1 is a large part of the hippocampus proper. Extensive projections have
been found between this area and other neural subdivisions and structures. Major
projections to CA1 are from other regions of the hippocampus and subdivisions of the
amygdala. Strong projections originating from within the hippocampus to the CA1
include those from the CA3 (Swanson and Cowan, 1977) and subicular region,
specifically the dorsal SUB (Witter et al., 1990). Strong projections originating from
outside the hippocampus include those from the BMA (Canteras et al., 1992) and BLA
(Savander et al., 1995) of the amygdala. Moderate projections to CA1 are from the LaN
(Petrovich et al., 2001), while weak projections to CA1 are from the dentate gyrus
(Swanson et al., 1978).
The CA1 sends projections to the four major amygdaloid subdvisions including
the BLA, BMA, CeN, and LaN (Ottersen, 1982; Kishi et al., 2006; Cenquizca and
Swanson, 2007). The CA1 provides weak projections to the primary auditory cortex
(Paperna and Malach, 1991).
Pyramidal cells are the main type of cells found in the CA1 area. The pyramidal
cells found in the CA1 are morphologically identifiable specifically as CA1 pyramidal
cells. They differ in cytoarchitecture from from other pyramidal cells found throughout
the hippocampus, i.e CA2-CA3, SUB pyramidal cells (Amaral and Lavenex, 2007).
Cornus ammonis 2 (CA2)
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The CA2 is found between CA1 and CA3 and is the smallest region of the
hippocampus proper. It is not studied as extensively as the other subdivisions.
Nevertheless, there evidence showing that the CA2 has projections to and from other
structures. Most incoming projections are from the amygdala, specifically the BLA and
BMA (Petrovich et al., 2001). Neurons in the CA2 project to the SUBd (Swanson and
Cowan, 1977). Other projections from the CA2 are relatively moderate/weak. Targets of
these projections include the primary auditory cortex (Paperna and Malach, 1991),
primary motor cortex (Reep et al., 1990), and primary visual cortex (Miller and Vogt,
1984).
The major type of cells in the CA2 are pyramidal cells. Morphologically these
appear smaller than the pyramidal cells found in the CA1, CA3, and SUB regions. This
allows for identification of CA2 pyramidal cells to be made possible. (Amaral and
Lavenex, 2007).
Cornus ammonis 3 (CA3)
The CA3 covers a larger area of the hippocampus proper. Major projections to
this hippocampal region include those from other hippocampal regions and from
structures outside the hippocampus. Other hippocampal regions providing projections to
the CA3 include the dentate gyrus (Swanson et al., 1978), the subiculum (Kohler, 1985),
and the CA1 (Swanson et al., 1981). Non-hippocampal regions sending major projections
to the CA3 include the BLA and BMA of the amygdala (Pikkarainen et al., 1999). The
CA3 sends projections to the CA1, ventral and dorsal SUB, CA2, and dentate gyrus
(Swanson and Cowan, 1977). CA3 also send projections to the olfactory bulb, dorsal
auditory cortex (Swanson and Cowan, 1977), and the visual cortex (Miller and Vogt,
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1984). Furthermore, projections from CA3 are sent to the BLA and BMA of the
amygdala (Swanson and Cowan, 1977).
The CA3 pyramidal cells are the main type of cells found in the CA3 region.
These cells branch out more than those found in CA1-CA2 regions (Amaral and Lavenex,
2007).
Dentate Gyrus (DG)
The DG is the largest subdivision within the hippocampus proper. Inputs to the
DG include those from the CA3 (Swanson and Cowan, 1977) and subiculum (Kohler,
1985). The BLA, BMA, and CeN of the amygdala also send projections to the dentate
gyrus (Petrovich et al., 2001). Major projections from the DG are sent to the CA3.
Projections are also sent to the subiculum and CA1 (Swanson et al., 1978) as well as to
the BLA and LaN regions of the amygdala (Ottersen, 1982).
Granule cells are the main type of cells in the DG. These cells are
morphologically very different from pyramidal cells found in other areas of the
hippocampus. Granule cells in the DG are not as densely packed and have different
orientations, in contrast to pyramidal cells in other hippocampal regions, which are
aligned with similar orientations in a thin sheet (Amaral and Lavenex, 2007).
Subiculum
The subiculum is considered to be a part of the hippocampus. However, it is not a
part of the hippocampus proper. The subiculum can be further subdivided into the dorsal
subiculum (SUBd) and the ventral subiculum (SUBv) (Verwer et al., 1997; Cenquizca
and Swanson, 2007). Differences exist between the two regions of the subiculum in fiber
innervation.
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The SUBd receives projections from the CA2 (Swanson and Cowan, 1977), CA3
(Swanson and Cowan, 1977), and DG (Swanson et al., 1978). The SUBd sends
projections to the CA1 and the SUBv (Swanson and Cowan, 1977). It also sends
projections to the BLA and BMA. Also, weak projections are provided by the subiculum
to the dorsal auditory cortex (Witter et al., 1990).
The SUBv receives projections from the CA3 (Swanson and Cowan, 1977) and
DG (Swanson et al., 1978). The SUBv sends major projections to the amygdala,
including the BLA, BMA (Kishi et al., 2006), LaN (Ottersen, 1982), and CeN (Canteras
and Swanson, 1992).
Projecting pyramidal cells are the major type of cells found in the SUB. These
cells are not as densely packed as the pyramidal cells in the CA1-CA3 region. However,
they do have a specific aligned orientations as seen in those regions. (Amaral and
Lavenex, 2007).
1.4.3 Auditory-limbic connections
The auditory and limbic structures are connected with one another through some
major areas. Overall, the auditory structures form direct connections with the amygdala
and indirect connections with the hippocampus (Kraus and Canlon, 2012). The MGN is
the key structure that sends direct projections to the LaN of the amygdala (Graybiel,
1972; Aitkin, 1986). The AC sends projections to the LaN (Kraus and Canlon, 2012).
The LaN then sends projections to the BLA, which sends direct projections to the CA1,
CA3 and indirect connections to the SUB (Kraus and Canlon, 2012).
Projections towards the auditory system from the limbic system involve direct
projections from the amygdala and indirect projections from the hippocampus. The CA1
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and SUB send projections to the LaN, BMA, and BLA in the amygdala. The BLA then
sends direct projections to the IC in the auditory pathway (Sah et al., 2003; LeDoux,
2007; Kraus and Canlon, 2012).
1.5 Neurotransmission in the central nervous system
Relay of signals from one neuron to the next is dependent on a synapse. At a
synapse, molecules of a specific neurotransmitter are released from a presynaptic
terminal and bind onto postsynaptic neurotransmitter receptors. There are a variety of
neurotransmitters found in the CNS including glutamate and gamma-aminobutryic acid
(GABA) (Silverthorn, 2013).
Neurotransmitter receptors can be either ionotropic or metabotropic. An
ionotropic receptor is also an ion channel. When bound by a neurotransmitter, such a
receptor opens the ion channel and allows for the movement of ions across the cell
membrane. An ion flux changes the membrane potential, leading to either an excitatory or
inhibitory effect depending on the species of ions moving across the cell membrane.
Generally, such an ion flux and membrane voltage change is short-lived (Purves et al.,
2001; Silverthorn, 2013).
A metabotropic receptor itself is not an ion channel. Such a receptor is coupled to
a guanine nucleotide-binding protein (G-protein). When a neurotransmitter molecule
binds onto the receptor, G-protein molecules are activated. Subunits of the G-protein
dissociate from each other. Dissociated G-protein subunits can directly modify ion
channels to either enhance or reduce their opening probability. The subunits can also
activate target proteins to produce second messengers, which in turn can initiate various
intracellular signaling cascades and lead to modification of ion channels. As a result,
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opening probabilities of these ion channels can be enhanced or suppressed. Enhanced or
suppressed ion fluxes can change the cell membrane voltage. Thus, a cell can be excited
or inhibited. Multiple steps between the activation of a metabotropic receptor and
changes in the opening probability of ion channels lead to a slow and long-lived
membrane voltage alteration (Purves et al, 2001; Silverthorn, 2013). Furthermore,
binding between one single receptor by a neurotransmitter can affect multiple ion
channels.
1.5.1 Glutamatergic neurotransmission
Glutamate is an amino acid neurotransmitter. Both ionotropic and metabotropic
glutamatergic receptors exist in the nervous system. Major ionotropic glutamatergic
receptors include the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptor, the N-methyl-D-aspartic-acid (NMDA) receptor, and the kainate receptor
(Silverthorn, 2013). Metabotropic glutamate receptors are divided into Group I (mGluR1
and mGluR5), Group II (mGluR2 and mGluR3), and Group III (mGluR4, mGluR6,
mGluR7 and mGluR 8) (Ferraguti and Shigemoto, 2006).
1.5.1.1 AMPA receptors
AMPA receptors are permeable to monovalent cations. After binding by
glutamate, an activated AMPA receptor allows sodium ions to move into a cell and
potassium ions to leave the cell. At or near the resting potential of a neuron, more sodium
ions enter the neuron than potassium ions leaving the neurons. The net ion influx leads to
an excitatory post-synaptic potential (EPSP) and a depolarization of the cell membrane
(Silverthorn, 2013).
1.5.1.2 NMDA receptors
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The NMDA receptors are different from the other ionotropic glutamatergic
receptors (i.e., AMPA and kainite receptors) in a few aspects. First, these receptors are
permeable to not only sodium and potassium ions, but also calcium ions. Second, the
activation of the receptors is dependent not only on binding by glutamate, but also on
other factors including binding by a co-agonist glycine and removal of blockage by
magnesium ions. The later is dependent on membrane depolarization, which is normally
provided by activation of AMPA receptors on the cell membrane. An activated NMDA
receptor allows for an influx of sodium and calcium ions and efflux of potassium ions.
The resulting net influx of cations leads to an EPSP and depolarization of the cell
membrane. As calcium can serve as a second messenger and affect many aspects of
intracellular signalling, the permeability of the NMDA receptor to this ion makes the
effect of activation of the receptor long lasting. It has been found in many structures of
the brain that tetanic stimulation of synaptic inputs can enhance the excitatory response of
a neurons and the enhancement of response can last for hours. Such an enhancement is
known as long-term potentiation and is largely dependent on the activation of the NMDA
receptors (Silverthorn, 2013).
1.5.1.3. Kainate receptors
Kainate receptors are similar to AMPA receptors. They exist in many structures
such as the hippocampus, cortex, spinal cord, and retina. In many cases, kainate receptors
are co-localized with AMPA and NMDA receptors. However, there are structures in
which kainate receptors exist without co-localied AMPA and NMDA receptors. These
structures include the retina, in which a synapse between a cone cell and an off-centre
bipolar cell is mediated by kainate receptors (Huettner, 2003).
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1.5.1.4. Metabotropic glutamatergic receptors
Metabotropic glutamate receptors are G-protein coupled receptors. These
receptors are found throughout the mammalian CNS. Activation of a metabotropic
glutamatergic receptor can lead to either an excitatory or an inhibitory response
depending on downstream signaling cascades including the specific cell membrane ion
channels modified (Ferraguti and Shigemoto, 2006).
1.5.2 GABAergic neurotransmission
GABA is a major inhibitory neurotransmitter found throughout the brain
(Silverthron, 2013). Almost 40% of the synapses in the brain are GABAergic (Malcangio
et al., 1996).
There are three subtypes of receptors to which GABA binds. These three are the
type-A, type-B, and type-C GABA receptors (GABAA, GABAB, and GABAC receptors)
(Enna, 2001). GABAA and GABAB receptors are found in all the major central auditory
processing centres, limbic structures including the amygdala and hippocampus, and
cerebellum (Chu et al., 1990; Wamsley et al., 1986; McCabe and Wamsley, 1986; Zezula
et al., 1988; Jamal et al., 2012; Liu et al., 2014). GABAC receptors, however, are mostly
found in the retina of vertebrae and are believed to be important for the processing of
visual information (Bormann and Feigesnspan, 1995).
1.5.2.1 Type-A and type-C GABA receptors
Both GABAA and GABAC receptors are ionotropic receptors that are permeable to
chloride ions upon activation. There are many isoforms of GABAA and GABAC
receptors. Each functional receptor is made up of five subunits that surround a central
channel, which is selective for chloride ions. Upon binding by GABA, the channel
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Figure 7: GABAB receptor mechanism pre- and post-synaptically. After the GABA
molecule binds to the GABAB receptor, the βϒ-subunit dissociates from the α-subunit. It
moves to the K+ or Ca2+ channels postsynaptically or presynaptically, respectively, and
leads to the opening of K+ channels and the closing of Ca2+ channels. [Chalifoux and
Carter, 2011]
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Figure 8: Protein conformation of a functional GABAB receptor with both subunits.
Blue: shows the GABABR1 subunit. Yellow: shows the GABABR2 subunit. Both
subunits have a venus flytrap (VFT) module and a heptahelical domain (HD). The VFT
module of the GABABR1 contains an area for GABA binding. The HD of the GABABR2
contains area associated with the G-protein. [Pin et al., 2003].
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becomes open, allowing negatively charged chloride ions to enter the cell and to cause an
inhibitory post-synaptic potential (IPSP) (Sigel and Steinmann, 2012).
1.5.2.2 Type-B GABA receptors
The GABAB receptor is a metabotropic receptor with more complex functions
than the ionotropic GABAergic receptors (Benke et al., 1999). GABAB receptors exist at
both presynaptic and postsynaptic sites. In general, binding of a GABAB receptor by
GABA leads to activation of a G-protein and subsequent modification of calcium or
potassium ion channels (Filippov et al., 2000).
Activation of a presynaptic GABAB receptor can regulate the release of
neurotransmitters including glutamate and GABA (Scholz and Miller, 1991; Mintz and
Bean, 1993, Obreitan and Van Den Pol, 1999). Following biunding of a GABAB receptor
by GABA, a G-protein trimer dissociates into the βϒ-subunit and α-subunit. The βϒsubunit modifies a voltage-gated calcium channel, decreasing influx of calcium ions and
thereby decreasing the release of neurotransmitters (Figure 7) (Herlitze et al., 1996;
Ikeda, 1996). Activation of postsynaptic GABAB receptors can result in an IPSP. After
GABA binds to a GABAB receptor, a G-protein dissociates into the βϒ-subunit and αsubunit. The βϒ-subunit modifies the inward rectifier potassium channels (GIRK), which
lead to enhanced potassium ion efflux and an IPSP (Figure 7) (Luscher et al., 1997;
Ulrich and Bettler, 2007).
1.5.2.2.1 Type-B GABA receptor subunits
A functional GABAB receptor is a heterodimer comprised of two subunits,
GABABR1 and GABABR2 (Kaupmann et al., 1998). The GABABR1 contains a venus
flytrap (VFT) module, a domain that is capable of binding to the ligand GABA (Figure 8)
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(Malitschek et al., 1999; Pin et al., 2004). The GABABR2 is coupled with a G-protein at
its heptahelical domain (HD) (Figure 8) (Robbins et al., 2001; Pin et al., 2004). The
GABABR1 has a retention signal that keeps it bound to the endoplasmic reticulum after
the subunit is made (Pin et al., 2004). The two subunits interact with their coiled-coil
domains. Once a heterodimer is formed between the two subunits, the retention signal is
masked and the dimeric receptor can be brought towards the plasma membrane to
become functional (Margeta-Mitrovic et al., 2000; Pagano et al., 2001).
GABABR1 consists of two splicing variants: GABABR1α and GABABR1β
(Bowery et al., 2002). They differ in the lengths of their N-terminus. GABABR1α
contains 163 amino acids in its N-terminus, whereas GABABR1β contains 47 amino
acids. The levels of the two splicing variants change over different developmental stages.
GABABR1α is highly expressed before birth, whereas GABABR1β is highly expressed in
adults (Fritschy et al., 1999). It is possible that GABABR2 has some variants as well,
however, these have not been characterized yet (Chalifoux and Carter, 2011).
1.5.2.2 Distribution of Type-B GABA receptors in auditory and limbic systems
GABAB receptors are found throughout all the major structures in the central
auditory system. Structures showing a high level of GABAB receptors include the ICd,
DCN, MGN, and AC (Fubara et al., 1996; Jamal et al., 2012). Lower levels are found in
the ventral and lateral parts of the IC, the NLL, the SOC, and ventral part of the CN. The
GABAB receptors also exist throughout the limbic system including both the
hippocampus and amygdala. The hippocampus contains GABAB receptors in all
subdivisions, however, the strongest labeling is found in the CA1 and CA3 pyramidal
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cells (Kulik et al., 2003). Immunohistochemistry and western blotting experiments have
confirmed the localization of GABAB receptors in the amygdala (Sah et al., 2003).
1.6 Neurotransmission and functions of the auditory and limbic systems
A balance between excitatory and inhibitory neurotransmission is critical for the
normal function of the brain. An imbalance between excitation and inhibition can lead to
changes in neural activity, which can have various behavioural consequences (Bauer et
al., 1999; Gerken et al., 1984). The pre- and postsynaptic functions of the GABAB
receptor makes this receptor especially important for regulating the balance between
excitation and inhibition.
In the central auditory system, a balance between excitation and inhibition is also
critical for maintaining appropriate activities and functions of auditory neurons
(Jastreboff and Sasaki, 1986; Chen and Jastreboff, 1995; Kenmochi and Eggermont,
1997). An abnormal reduction in inhibition and/or increase in excitation can lead to
epileptiform firing of action potentials in an auditory neuron. Such a type of neural firing
can certainly affect an auditory perception (Guitton et al., 2003; Guitton and Puel, 2004).
Functions of the hippocampus (Salvi et al., 2011) and the amygdala (De Ridder et
al., 2006) also rely on the balance between excitation and inhibition. The main functions
of the amygdala and hippocampus are emotion and memory, respectively. A proper
balance between excitation and inhibition is required for these structures to function. A
change to the balance can lead to differences in the functionality. An increase in activity
in both structures is possible, which can be due to an increase in excitatory
neurotransmission or a decrease in inhibitory neurotransmission (Chen et al., 2012).
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Physiological studies have revealed that GABAB receptors are involved in the
regulation of sound-driven responses in auditory structures (Faingold et al., 1989;
Vaughan et al., 1996; Szcepanial and Moller, 1996). GABAB receptors in limbic
structures are important for the activity of neurons, which are implicated in higher
functions of the brain including stress and anxiety (Cryan and Kaupmann, 2005).
Therefore, a change in GABAB receptors can affect auditory functions as well as stress
and anxiety.
1.7 Tinnitus
Tinnitus, i.e., ringing in the ear, is amongst the major types of hearing problems.
An individual with tinnitus has a phantom sensation of sounds even when there is no
stimulus present in the acoustic environment. Reported phantom sensations associated
with tinnitus include ringing, buzzing, cricket-like sining, hissing, whistling, and
humming (Canadian Academy of Audiology). Tinnitus affects a reported 360,000
Canadians, of which 150,000 having their quality of life severely compromised
(Canadian Academy of Audiology).
A study conducted by Axelsson and Ringdahi (1989) on 3,600 randomly selected
adults in the general population revealed that 14.2% of the subjects had chronic tinnitus
throughout the day. The remaining individuals experienced transient tinnitus. Also, males
were more affected than females and the left ear was more affected than the right. Two
point four percent of the people in the study group were affected to such a degree that
their quality of life was severely affected. Among the affected aspects of life is the
quality of sleep. They found a positive correlation between tinnitus severity and sleep
disturbances.
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1.7.1 Objective vs. subjective tinnitus
1.7.1.1 Objective tinnitus
Objective tinnitus is a type of sensation caused by sounds generated within the
peripheral auditory system (but not external environment) (Lockwood et al., 2002). There
are three known causes of objective tinnitus. A tinnitus sensation with a pulsatile sound
quality is usually caused by turbulent flow of blood in vessels near the cochlea
(Weissman and Hirsch, 2000; Lockwood et al., 2002; Liyanage et al., 2006; Sonmez et
al., 2007). The cause of this problem is linked to artery/vein malformations (or other
vascular abnormalities), heart disease, high cardiac output, and other problems that may
lead to turbulent blood flow (Lockwood et al., 2002). A tinnitus sensation with a clicking
or low-pitched buzzing sound quality may be due to involuntary muscular contractions in
the middle ear, specifically in the tensor tympani or stapedius muscle (Lockwood et al.,
2002; Abdul-Baqi, 2004; Howsam et al., 2005). This can be caused by a spasm that
occurs in the stapedius or tensor tymapni muscle (Lockwood et al., 2002). A tinnitus
sensation of environmental sound, may be due to irregular stimulation of outer hair cells.
The cause of this is known to be spontaneous activation of acoustic emissions (Lockwood
et al., 2002).
1.7.1.2 Subjective tinnitus
Subjective tinnitus is sometimes interchangeably referred to as tinnitus
(Lockwood et al., 2002). People with this form of tinnitus report hearing phantom sounds
when there is no actual acoustic stimulation presented either in the external environment
or within the body.
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Figure 9: Molecular structures of sodium salicylate and acetylsalicylic acid (i.e.
aspirin).
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It is believed that subjective tinnitus is due to changes in the peripheral and/or
central nervous system (Jastreboff, 1990; Lockwood et al., 2002; Moller, 2003;
Rauschecker et al., 2010). Evidence supporting the central origin of tinnitus comes from
the fact that blocking inputs to the central auditory system does not eliminate phantom
sensations of sounds (House and Brackman, 1981; Barrs and Brackman, 1984; Berliner et
al., 1992; Kaltenbach et al, 2005).
Subjective tinnitus can be induced by otologic, neurologic, infectious, or drugrelated factors. Otologic factors are associated with noise-induced hearing loss,
presbycusis (i.e., age-dependent hearing loss), deafness, or any other cause of hearing
loss. Neurological factors include head injury and multiple sclerosis. Infectious factors
include otitis media, meningitis, syphilis, or any other infectious disease that can lead to
hearing abnormalities. Drug-related factors include aminoglycoside antibiotics and
various over-the-counter and prescription drugs that are used for treating inflammatory
problems. Two examples of anti-inflammatory drugs are Aspirin and sodium salicylate
(SS).
1.8 Aspirin- and SS-induced tinnitus
Aspirin is available in North America as both an over-the-counter drug and a
prescription drug. Prescription aspirin is generally used for relieving pain caused by more
serious problems such as rheumatoid arthritis, osteoarthritis, and other rheumatologic
conditions. In North America alone, about one hundred and twenty billion pills are
prescribed each year (Warner and Mitchell, 2002). Effects of the drug are related to the
inhibition of cyclooxygenase, which decreases prostaglandin production (Gong et al.,
2008). As a nonprescription drug, aspirin is used to relieve moderate pain from
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headaches, menstrual cramps, toothaches, and muscle aches (NIH, 2016). The drug is
capable of having such a widespread effect throughout the body because of its ability to
reach systemic circulation (Rowland et al., 1972). After an oral dose is taken, the drug
hydrolyzes to salicylic acids (Figure 9) and acetic acids (Rowland et al, 1972) of which
the salicylic acid reaches peak plasma levels within 1-2 hours. The salicylic acid becomes
widely distributed to many areas of the body including the central nervous system (Bayer
Corp. USA).
Salicylate itself has been administered to individuals to help treat various health
problems such as advanced myelodysplastic syndrome, acute myelogenous, leukemia,
and chronic lymphocytic leukemia. It is reported that the drug can reduce the incidence of
cancer and enhance the survival rate of cancer patients (Klimek et al., 2012).
Despite the benefits, Aspirin and other salicylic drugs have side effects include
nausea, vomiting, stomachache, and heartburn. It also causes hives, rash, difficulty in
breathing, and swelling. The drugs also cause hearing problems including transient
tinnitus and hearing loss. For Apirin, it is likely that its toxicity is produced by its
metabolite salicylic acid. Therefore, it is sodium salicylate (SS) that is currently used by
most of researchers in the study of ototoxic effects (e.g., tinnitus) of Aspirin and other
salicylic drugs (Temple, 1978; Krause et al., 1992; Dargan et al., 2002).
1.8.1 SS induces tinnitus in humans
Many studies have been conducted in which patients have been study to
understand how SS can cause the sensation of tinnitus. Furthermore, Studies have been
conducted to find the plasma level of SS required to induce tinnitus in human subjects to
understand the toxic levels. An early study based on salicylate injections revealed that SS
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at a blood concentration of 200mg/L can led to tinnitus in human subjects (Jagar and
Always, 1946). When administered orally, salicylate can lead to deafness at a
concentration of 250mg/L (Graham and Parker, 1948). Many subsequent studies also
used oral administration of SS and found that tinnitus can be induced at blood
concentrations of below 100mgl/L to 250mg/L (Myers et al., 1965; McCabe and Day,
1965; Mongan et al., 1973; Halla et al., 1991; Janssen et al., 2000).
1.8.2 Tinnitus-like behaviour induced by SS in animals
Behavioural paradigms have been developed to assess the induction of tinnituslike behaviour in animals. Some behavioural tests are based on conditioned suppression
paradigms, which use water as a reward and foot-shocks as a punishment to shape animal
behaviours. An animal is trained to obtain water reward through licking a drinking spout
in the presence of a background sound and stop licking in the absence of the background
sound. Failing to stop licking in the absence of the background sound following treatment
of SS is interpreted as that the animal perceives a phantom sound in the absence of the
background sound (i.e., showing a tinnitus behaviour). Using this behavioural paradigm,
early studies found that SS applied systemically at a dosage of 300mg/kg could reliably
induce tinnitus-like behavior in the rat (Jastreboff et al., 1988; Jastreboff and Sasaki,
1994). Late studies indicate that the degree of tinnitus seems to be correlated with the
dosage of SS within a range from 50 to 300mg/kg. Researchers also examined the blood
salicylate concentration required for inducing tinnitus in the rat. Results closely resemble
those from human subjects.
1.8.3 Neurobiological changes caused by SS
1.8.3.1 SS-induced changes in the auditory sensory organ
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In the peripheral auditory system, SS primarily affects outer hair cells in the
cochlea. It is well known that outer hair cells can change their length in response to
depolarization/hyperpolarization. Such an “electromotility” can enhance the sensitivity of
the auditory sensory organ to sound stimulation. It has been found that SS can bind the
motor protein prestin in the outer hair cells and reduce the electromotility of these cells
(Shehata et al., 1991; Oliver et al., 2000; Chen et al., 2010). This can lead to a reduction
in the output signal from the cochlea to the central nervous system. A reduction in
cochlea output have been confirmed following systemic application (Cazals, 2000) as
well as local application (in the cochlea) (Muller et al., 2009) of SS.
1.8.3.2 SS-induced neurobiological changes in the central auditory system
Tinnitus-like behaviour has been reported in animals even after the auditory nerve
fibers are disconnected from the brain (Berliner et al., 1992). This leads one to believe
that there are central changes that are taking place.
1.8.3.2.1 Effect of SS on the CN
The CN is the first auditory structure to receive information from the peripheral
nervous system. Previous studies have shown the involvement of the CN in SS-induced
tinnitus (Brozoski et al., 2002; Kaltenbach and Godfrey, 2008; Shore et al., 2007).
Neurophysiological studies conducted using brain slice preparations have found that after
SS application, the CN showed an increase in activity (Basta et al., 2008; Wei et al.,
2010). Another study based on manganese enhanced functional magnetic resonance
imaging found that systemic application of SS cased an increase in activity in the DCN
but no change in the VCN (Holt et al., 2010).
1.8.3.2.2 Effect of SS on the IC
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The IC is a key structure involved in the processing of auditory information.
Studies have been conducted on this auditory structure to find how it’s involved in
tinnitus (Manabe et al., 1997; Bauer et al., 2000). An increase in the expression of an
immediate early gene c-fos has been observed in the IC following application of SS,
suggesting that neural activity in this structure can be increase by the drug (Wu et al.,
2003). A study based on manganese enhanced functional magnetic resonance imaging
has supported that a systemic application of SS can increase the response in the IC, with
the largest increase observed in the ICd (Holt et al., 2010). In vivo neurophysiological
recordings confirmed a systemic application of SS can increase neural activities in the
ICd and ICx (Jastreboff and Saskaki, 1986; Chen and Jastreboff, 1995; Manabe et al.,
1997). Recordings from brain slice preparations showed that SS has a local target in the
IC (Basta and Ernst, 2000). This result has been supported by our own results obtained by
using in vivo neurophysiological recording/neuropharmacological manipulations (Patel
and Zhang, 2014).
1.8.3.2.3 Effect of SS on the MGN
In spite of the importance of the MGN in auditory processing, not much attention
has been paid to the role of this structure in the induction/generation of tinnitus. A study
conducted by Basta and colleagues (2008) examined SS-induced changes in neural
activity in the dorsal and ventral MGN using brain slice preparations. They found that SS
enhanced activity in the MGN. In contrast to this finding, another brain slice study
suggested that SS reduced firing of intrinsic action potentials in the MGN (Su et al.,
2012) studied the activity in the MGN after SS-application.
1.8.3.2.4 Effect of SS on the AC
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The effect of SS on neurons in the AC has been extensively studied. Many studies
have yieled comparable results. It has been found that SS increases spontaneous neural
activity in a brain slice preparation. The increase in neural activity was dose-dependent
(Basta et al., 2008). An in vivo study indicates that a systemic application of salicylate
can increase sound-evoked neural activity in the AC (Yang et al., 2007). In another study,
they used systemic and local application of SS. They found that sound-evoked neural
activity increased, however, the spontaneous firing had reduced (Lu et al., 2011).
1.8.3.3 Effects of SS on limbic structures
1.8.3.3.1 Effect of SS on the amygdala
Recent studies have examined the effect SS on limbic structures, including the
amygdala. Chen and colleagues (2014) used a rat model to study the effect of a systemic
application of SS. Behavioural tests were conducted to ensure that a tinnitus-like
behaviour was induced and in vivo recordings were conducted in the LaN of the
amygdala. An SS-induced increase in neural activity was found. Neurochemical changes
in the amygdala were also examined following a systemic application of salicylate.
Immunocytochemical experiments revealed that expressions of arg3.1 and c-fos, which
reflect the level of neural activity, were increased substantially in the structure following
the drug application (Mahlke and Wallhausser-Franke, 2004). The largest change was
found in the CeN.
1.8.3.3.2 Effects of SS on the hippocampus
Studies have also examined the effect of SS on the hippocampus. In these studies,
SS was applied systemically and behavioural tests were conducted to ensure that a
tinnitus-like behavior was induced in experimental subjects. In vivo electrophysiological
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recordings were then conducted in these animals. Results indicate that the drug causes an
increase in activity in the hippocampus (Chen et al., 2014). An in vitro study conducted
on the CA1 region of the hippocampus was also explored. Researchers found an increase
in neuronal activation, following systemic application of salicylate (Gong et al., 2008).
1.9 Possible central mechanisms underlying SS-induced tinnitus
1.9.1 Tipping of balance between excitation and inhibition in auditory structures
It is believed by many researchers that tinnitus is dependent on
neurophysiological changes in central auditory structures. These changes can include
enhanced excitation and/or reduced inhibition, which can lead to excessive firing of
action potential in the absence of external acoustic stimulation.
Previous research has studied the effects of SS on the neural activity in the
cochlea and the major auditory structures involved in tinnitus. From in vivo studies it was
found that following a systemic application of SS, there was a decrease in sound-evoked
activity in the cochlea (Muller et al., 2009). Further studies found SS caused a decrease in
the electromotility of OHCs, which caused a decrease in signal output (Shehata et al.,
1991; Oliver et al., 2000; Chen et al., 2010). In contrast to the decrease in the output at
the periphery, there is an increase in activity at the central structures. As mentioned in
sections 1.8.3.2.1 – 1.8.3.2.4, there is generally an increase in activity of the auditory
structures after SS-administration, with the exception of the MGN, which is indifferent
(Basta and Ernst, 2000; Basta et al., 2008; Chen et al., 2014). Studying the structures in
the ascending pathway could give better insight to this discrepancy.
An increase in neural activity in central auditory structures is supported by
functional imaging studies. Using the manganese enhanced magnetic resonance imaging
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technique, Holt and colleagues (2010) found a widespread increase in neural activity in
the central auditory system with the increase being highest in the DCN and ICd. In vitro
neurophysiological studies also support that SS can enhance neural activities in central
auditory structures. The recordings showed a reduction in GABA-mediated inhibition,
which lead to an increase in excitatory potential (Wang et al, 2008; Gong et al., 2008).
Studies also focused on the GABAergic inhibition to understand the increase in activity
in the AC. They found that there was a reduction here as well (Sun et al., 2009; Lu et al.,
2011). However, there also exist inconclusive findings in which studies have shown a
decrease or no significant change in activity (Basta and Ernst, 2004 Eggermont and
Roberts, 2004; Ma et al., 2006). More studies are required to understand the molecular
changes after tinnitus is induced (Knipper et al., 2009).
An SS-induced increase in auditory neural activity could be due to effects of the
drug on the abundance of neurotransmitter and/or neurotransmitter receptors in auditory
neural structures. Butt and colleagues (2016) have found a decrease in level of GABAB
receptors in the IC after a systemic application of SS. Zou and Shang (2012) studied the
neurochemical changes that occur in GABAA receptors and GABA decarboxylase
(GAD), which is an enzyme required for synthesizing GABA. They found a reduction in
both levels in the CAS after the application of the SS. Similar studies have been done by
Basta and colleagues (2000), which also found a reduction in the GABAA receptors after
SS-application.
Existing results have looked at how SS can cause changes in the expression of
proteins. Some proteins are involved in contributing to both inhibitory and excitatory
neurotransmission. These changes are most likely slower because they require the change
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of cellular mechanisms. Researchers found a reduction in the mRNA expression of the
GABAAα1 subunit. They also found a reduction in the mRNA expression of the enzyme
GAD67 (Zou and Shang, 2012). In other studies an increase in the mRNA expression of
NMDA receptor subunit 2A was found in the CN after SS administration (Hu et al.,
2014).
1.9.2 Synchronization and bursting activity of auditory neurons
Other neurophysiological changes that may lead to a phantom sensation of sound
include synchronization among activities generated by an ensemble of neurons. They also
include enhanced bursting of action potential firing in auditory neurons. Both of these
changes can be associated with reduction in inhibition. Following SS application, an
increase in bursting activity was found in the IC (Chen and Jastreboff, 1995; Kwon et al.,
1999), while an increase in synchronization was seen in the auditory nerve (Cazals et al.,
1998). Studies based on electroencephalography and magnetoencephalograhy in human
subjects supports an enhancement in synchronization in auditory cortical areas (Weisz et
al., 2005; Schlee et al., 2009).
1.9.3 Involvement of limbic structures
The induction/manifestation of tinnitus may be dependent on regulation by other
neural structures. Inputs from these structures may influence auditory neurons and cause
abnormalities in physiological functions of these neurons. The limbic system is likely
involved in the regulation of auditory neural activities (Lockwood et al., 1998; Mahlke
and Walhausser-Franke, 2004; Vlassenko et al., 2010; Kraus et al., 2012). Early evidence
supporting the involvement of the limbic system includes that tinnitus can be modulated
emotional distress (Jastreboff, 1990; Sullivan et al., 1998; Dobie, 2003). Such
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observations are supported by recent studies showing strong associations between tinnitus
and emotional stress, anxiety, and depression (Langguth, 2011).
Anatomical studies indicate that the amygdala has direct connections with the
MGN, while the hippocampus has indirect connections (See section 1.4). These
connections likely serve as a gating mechanism that regulate the relay of neural signals
from the MGN to the AC. Malfunction of this gating mechanism affect the relay of
signals in the ascending auditory system (Leaver et al., 2011) which may contribute to the
induction/manifestation of tinnitus. Such malfunction is likely important for the
persistence of chronic tinnitus (Knipper et al., 2009; Galazyuk et al., 2012).
Knowledge about SS-induced changes in neurophysiological mechanisms and
how these changes are dependent on neurochemical alterations in limbic structures is
critical for understanding the involvement of these structures in the
induction/manifestation of tinnitus. An important aspect of this knowledge is related to
GABAergic neurotransmission. Researchers studied a molecule, i.e. GAD1, which is
required to synthesize GABA. They found an increase, i.e. an upregulation in the level of
this molecule (lm et al., 2007). It is equally importantly to study how SS affects the level
of the GABAergic receptors in the limbic structures. It is especially important to study
the level of the GABAB receptors. A GABAB receptor exists at both pre- and postsynaptic
sites, the receptor possibly plays a major role in the regulation of excitation and inhibition
in the limbic structures, which can consequently affect the level of activity in the central
auditory system through limbic-thalamic projections.
1.10 Research objectives and hypothesis
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The specific objective of this thesis was to understand how systemic application
of SS affects the level of GABAB receptors in the amygdala and hippocampus of a rat. I
wanted to find whether the changes were localized to specific subdivisions of the
amygdala and hippocampus. Based on previous findings, I hypothesized that the drug
would cause an increase in the level of GABAB receptors in both structures.
2 Experimental methods
Immunohistochemistry experiments were conducted to study the level of GABAB
receptors in the rat’s auditory structures. Techniques used in this study were well
established by previous members in my lab (Jamal et al., 2011; Jamal et al., 2012; Butt et
al., 2016).
2.1 Animal preparation
Experiments were conducted using 250-350g male Wistar rats (Rattus norvegicus)
obtained from Charles River Laboratories Inc. (St. Constant, QC). They were housed in
the University of Windsor Animal Care Facility (with a noise level of 50-60 dB SPL) for
at least a week before experiments were conducted. All procedures were done in
accordance with the Canadian Council on Animal Care guidelines.
Pairs of animals received either an intraperitoneal injection of SS (250mg/kg, i.p.)
or an equivalent volume of physiological saline (PS). A survival period of three hours
was given to allow SS-treated rats to develop a tinnitus-like behaviour (Jastreboff and
Sasaki, 1994). Animals were euthanized with an overdose of sodium pentobarbital
(120mg/kg, i.p.) and perfused with 200ml phosphate-buffered saline (PBS, 0.1M, pH 7.1)
followed by 200ml paraformaldehyde (4% in PBS). Then the brains were extracted,
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cryoprotected in 30% sucrose (in PBS), and sectioned along the coronal plane at 30µm
using a cryostat (Leica Microsystems CM1050 S, Heidelberg, Germany).
2.2 Immunohistochemical (IHC) experiments
2.2.1 Experimental procedures
An experiment was conducted by using tissue sections from the hippocampal and
amygdala from a pair of PS- and SS-treated animals. For each structure (i.e., amygdala or
hippocampus) of each animal, the sections were taken from the whole rostrocaudal extent
of the structure at 300µm intervals. Sections from similar rostrocaudal locations of PSand SS-treated animals were placed next to each other on a microscope slide (Figure 10).
All the sections from a pair of animals were placed on four microscope slides. Each slide
contained two cerebellar sections from PS- and SS- treated animals, respectively. These
cerebellar sections were used as a positive control (Benke et al., 2002; Charles et al.,
2001; Ige et al., 2000). They were also used for providing references for normalization
(Butt et al., 2016; also see Section 2.3). Throughout an entire immunohistochemical
experiment, the four microscope slides were placed in the same slide jars to ensure that
the same experimental conditions were applied to all the tissue sections.
For each reaction, the tissues were first incubated for 22 hours in a primary
antibody (see “Antibodies” section) in 0.1M PBS containing 0.05% Triton and 5%
normal donkey serum. After three rinses (10 minute each) with 0.1M PBS, the tissues
were incubated in a secondary antibody (see “Antibodies” section) in 0.1M PBS with 2%
normal donkey serum for 2 hours. After another three rinses of 0.1M PBS (10 minutes
each), tissues were incubated in ExtraAvidin-Peroxidase (1:400 in 0.1M PBS, SigmaAldrich E2886, Oakville, ON) for 1.5 hours. The tissues were then rinsed in 0.1M PBS

47

Figure 10: Schematic diagram of a microscope slide showing the organization of
brain slices. Gray area: naming system showing a sample naming. White area: showing
where the slices were collected. PS CBM is the cerebellum from the PS-treated animal.
SS CBM is the cerebellum from the SS-treated animal. PS 1-5 represents the limbic
structures from the PS-treated animal. SS 1-5 represents the limbic structures from the
SS-treated animal. The top row matches the bottom row in rostrocaudal location.
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(10 minutes each) and stained with 3’3’ diaminobenzidine tetrahydrochloride in 0.1Mphosphate buffer. Distilled water was used to stop the staining reaction. The tissue was
then dehydrated using an ethanol gradient (60%, 70%, 95%, 100%, and 100%, 5 minutes
per concentration) and cleared with two charges of histosol (10 minutes each). Finally,
slides were coverslipped with the mounting medium, Permount (Fisher Scientific SP-500,
Ottawa, ON).
2.2.2 Antibodies
The primary antibody against GABABR1 subunit was rabbit polyclonal
GABABR1 antiserum (Santa Cruz Biotechnology R-300, 1:500). The primary antibody
against GABABR2 subunit was guinea-pig polyclonal GABABR2 antiserum (Chemicon
AB5394, 1:1000).
The secondary antibody for probing GABABR1 subunit was biotinylated donkey
anti-rabbit IgG (Jackson ImmnoResearch Laboratories 711-005-152, 1:400, Temecula,
CA). The secondary antibody for probing GABABR2 subunit was biotinylated donkey
anti-guinea pig IgG (Jackson ImmunoResearch Laboratories 706-065-148, 1:400,
Burlington, ON).
2.2.3 Positive and negative control experiments
Both negative and positive control experiments were conducted. Positive control
experiments were conducted by using tissues from the cerebellum as previous studies
have indicated that both GABABR1 and GABABR2 exist in this structure with the level
being high in the molecular layer. My positive experiments revealed that antibodies for
probing both GABABR1 and GABABR2 subunits were effective.
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A negative control experiment was conducted using the same procedures as that
described in section 2.2.1 with a primary antibody (against GABABR1 or GABABR2) or
a secondary antibody (for probing GABABR1 and GABABR2) omitted. Negative control
experiments revealed no labeling in either cell body or neuropil regions in the limbic and
cerebellar tissues, indicating that the labeling in limbic structures in normal IHC
experiments was specific.
2.3 Data analysis
Images of the sections subjected to IHC reactions were taken using a CTR 6500
microscope and a DFC 425 digital camera (Leica Microsystems, Heidelberg, Germany).
A piece of standard tissue was used to set light intensity and exposure. The same lighting
condition was used across different imaging sessions to allow for quantitative comparison
among images taken in different sessions.
Immunoreactivity was quatified using the LAS V4.5 software (Leica
Microsystems, Heidelberg, Germany). An optic density (OD) was measured at each pixel
to reflect the level of immunoreactivity. A mean OD was obtained for a target area or
object (e.g., a cell body) by using the ODs obtained at all pixels within the target area or
object. Immunoreactive cell bodies were identified using a threshold criterion. A
threshold value was set for each individual slice as the mean OD of all the pixels in the
neuropil region surrounding cell bodies minus three standard deviations of all the ODs at
these pixels. For the amygdala, an additional length criterion was used. Only objects that
passed the threshold criterion and with their longest axes in a range between 4 and 26
micrometer were included. Visual examination was also used to help identify the
immunoreactive cell bodies.
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To compare the level of immunoreactivity in a target area or a group of labeled
neurons between a pair of SS- and PS-treated animals, the mean OD value of the target
area or each neuron in the group was normalized using the OD values from the molecular
layer and the white matter of the cerebellum. The level of GABAB receptors in the
cerebellum is not affected by the systemic application of SS (Butt et al., 2016)
IRN = (ODLS – ODWM)/(ODMol – ODWM)
where IRN is a normalized level of immunoreactivity of a hippocampal or amygdaloid
area or cell body. ODLS, ODWM, ODMol are the mean OD values of a cell body/area in the
limbic structure of interest (i.e. hippocampus or amygdala), the white matter of the
hippocampus, and the molecular layer of the cerebellum, respectively. The OD values
from the cerebellar regions were used in normalization as our previous study indicated
that these values are not affected by systemic application of SS (Figure 12; also see Butt
et al., 2016).
2.3.1 Statistical analysis
All bar charts represent the mean OD ± standard deviation. Based on the specific
data sets, a two-tail t-test or a two-way ANOVA was conducted. A level of p < 0.05 was
considered to be statistically significant.
3 Results
3.1 Control experiments and the effect of SS on GABAB receptors in the cerebellum
Positive and negative control experiments were conducted to ensure the
effectiveness of antibodies and the reliability of IHC results. To ensure that antibodies
were effective in probing the GABABR1 or GABABR2 subunits, positive control
experiments were conducted by using tissues from the cerebellum as both subunits exist
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Figure 11: Positive and negative control using cerebellum tissue. M: molecular layer,
G: granular layer, W: white matter. Top panel shows a positive control by showing the
immunolabeling in the cerebellum by probing both GABABR1 and GABABR2. Middle
panel shows a negative control by omitting the primary antibody for GABABR1 and
GABABR2. Bottom panel shows a negative control by omitting the secondary antibody
for GABABR1 and GABABR2. Scale bar: 100µm.
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in this brain structure (Jamal et al., 2012). In all the six pairs of animals examined in this
study, I conducted IHC experiments against the GABABR1 and GABABR2 subunits
using pairs of cerebellar tissues from the PS- and SS-treated animals. These experiments
revealed clearly labeled cells including large Purkinje cells (Figure 11). The neuropil
regions surrounding these cells were also labeled. These results suggest that the
antibodies used in our study were effective.
Negative control experiments were conducted by using cerebellar tissue from one
pair (i.e. one case) of animals. These experiments were conducted by omitting either the
primary or secondary antibody for probing the GABABR1 or GABABR2 subunit while all
the other experimental procedures were kept exactly the same as those described in the
“immunohistochemical (IHC) experiments” section. The experiments revealed very faint
labeling of cell bodies and surrounding neuropil regions, suggesting that the antibodies
used in the present study was specific in labeling the GABABR1 or GABABR2 subunits
(Figure 11).
The level of labeling in the molecular layer of the cerebellum was quantified for
both the GABABR1 and GABABR2 subunits in six cases. Results revealed that SS did not
affect the level of either of the GABAB receptor subunits (Figure 12). The quantification
showed no significant difference between the two treatments (two-tail T-test; 0.158; 6).
These results agree with that revealed by a previous study from our lab (Butt et al., 2016).
The lack of the effect of SS on the level of receptor subunits in the molecular layer of the
cerebellum suggest that any changes observed in the amygdala and hippocampus were
specific to these limbic structures.
3.2 Effect of SS on the level of GABAB receptor subunits in the amygdala
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Figure 12: No change in molecular layer of cerebellum in SS-treated animals. (A)
low magnification images of cerebellum from PS- and SS-treated animals probed with
GABABR1 and GABABR2. (B) group results showing little change between the
molecular layers of PS- and SS-treated in both subunits. Results are from six pairs of
animals. Change is not statistically significant (two-tail T-test (5); t = 0.8296; p = 0.158).
Scale bar: 100µm.
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3.2.1 Normative immunoreactivities against GABABR1 and GABABR2 in the
amygdala
Results from six PS- treated animals were examined to understand the normative
immunoreactivities against GABABR1 and GABABR2. For both subunits, an
immunoreactivity was observed throughout the entire structure. The level of labeling was
reduced from the rostral to the caudal part of the structure. A closer examination revealed
a similar level of labeling in BLA, BMA, and LA, and a higher level of labeling in the
CeN. This was consistent throughout the rostrocaudal extent of the structure.
3.2.2 Effect of SS on the overall level of receptor subunits in the amygdala
The effect of SS on the level of GABABR1 and GABABR2 in amygdala was
studied in six pairs of PS- and SS-treated animals. Results were quantified in all six cases.
For each animal, ten tissue sections containing the amygdala and one section containing
the cerebellum were used in IHC experiments.
As shown by an example in Figure 13, levels of immunoreactivity were similar
between cerebellum tissues obtained from the PS- and SS-treated animals for both the
GABABR1 and GABABR2 (Figure 13 top row). In contrast, the level of labeling in the
amygdala was higher in the SS-treated than the PS-treated animal for both subunits
(Figure 13 middle and bottom rows).
The level of labeling was compared between PS- and SS-treated animals over the
rostrocaudal extent of the amygdala. For both the GABABR1 and GABABR2 subunits, SS
resulted in an overall increase in immunolabeling throughout the entire extent (Figure 14
and Figure 15). The increase tended to be larger in the caudal than the rostral part of the
structure.
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Figure 13: Change in overall mean OD of SS-treated animals in the amygdala. (A)
shows immunolabeling against GABABR1 subunit and (B) shows the immunolabeling
against the GABABR2 subunit in the cerebellum (top panel) and amygdala (bottom panel)
in both PS- and SS-treated animals. Scale bar: 300µm.
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Figure 14: Immunolabeling against GABABR1 in the rostrocaudal slices of the
amygdala. Major subdivisions are outlined. Scale bar: 300µm.
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Figure 15: Immunolabeling against GABABR2 in the rostrocaudal slices of the
amygdala. Major subdivisions are outlined. Scale bar: 300µm.
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Figure 16: Group results from IHC experiments showing overall changes in
normalized OD values of the amygdala in both GABABR1 and GABABR2 subunits.
Results were combined from the OD of the major subdivisions and then normalized the
cerebellum from the specific IHC experiment. Results are from six pairs of animals. The
change is statistically significant for both GABABR1 (two-tail T-test (22); t=3.5524
p<0.005) and GABABR2 (two-tail T-test (22); t=4.8263; p<0.001).
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A weighted average OD was used to evaluate the overall level of
immunoreactivity against a receptor subunit (GABABR1 or GABABR2) in the amygdala
of an animal. Results from 3 pairs of animals reveled that SS produced an overall
increase in level of both receptor subunits (Figure 16), with the increase being
statistically significant for both GABABR1 (two-tail T-test; p<0.005; n=6) and
GABABR2 (two-tail T-test; p<0.001; n=6).
3.2.3 Effects of SS in major amygdaloid subdivisions
Six cases were analyzed to study the effect off SS on the GABABR1 and
GABABR2 subunits in the four major subdivisions of the amygdala. A weighted average
OD was obtained for each subdivision of the structure. For the GABABR1 subunit, results
from 6 pairs of PS- and SS-treated animals indicate that the increase was similar among
the subdivisions including the BLA, BMA, and CeN, and slightly larger in LaN (Figure
17 and Figure 19a). The rostral slices became more area specific, showing a larger
increase in labeling in the LaN, compared to other subdivisions. The increase in all the
subdivisions was statistically significant (two-way ANOVA; p<0.001; n=6).
The effect of SS on the GABABR2 subunit was also evaluated in the four major
amygdaloid subdivisions. Results indicate that the level of the receptor subunit was
increased in all the subdivisions. The SS-induced increase was similar among the BLA,
BMA, and CeN, but some how larger in the LaN (Figure 18 and Figure 19b). The
increase in all the subdivisions were statistically significant (two-way ANOVA; p<0.05;
n=6).
3.2.4 The effect of SS on immunoreactivities in cell bodies
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Figure 17: High magnification images of the major subdivisions of the amygdala
labeled against GABABR1. Low magnification images show the different subdivisions
for the PS and SS-treated animals. Corresponding high magnification images are from the
specific subdivisions. Low magnification image scale bar: 300µm. High magnification
image scale bar: 25µm.
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Figure 18: High magnification images of the major subdivisions of the amygdala
labeled against GABABR2. Low magnification images show the different subdivisions
for the PS and SS-treated animals. Corresponding high magnification images are from the
specific subdivisions. Low magnification image scale bar: 300µm. High magnification
image scale bar: 25µm.
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Figure 19: Group results from IHC experiments showing overall changes in
normalized OD values of the major subdivisions of the amygdala in both GABABR1
and GABABR2 subunits. Results were normalized against the cerebellum from the
specific IHC experiment. Results are statistically significant for both GABABR1 two-way
ANOVA (22); p<0.001; n=6) and GABABR2 (two-way ANOVA (22); p<0.05; n=6).
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Figure 20: High magnification images showing immunolabeled cells against
GABABR1 and GABABR2 in the four major subdivisions of the amygdala. Both PSand SS-treated labeled against GABABR1 and GABABR2 in all subdivisions including
the (A) BLA, (B) BMA, (C) CeN, and (D) LaN. Scale bar: 10µm.
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For both the GABABR1 and GABABR1 subunits, the effect of SS on the level of
immunoreactivity was studied in cellular regions in six cases. High magnification images
indicate that the overall increase in the level of immunoreactivity against the receptor
subunits was highly dependent on the increase in cell body regions. Further observations
indicated a difference in the pattern of labeling between the GABABR1 and GABABR2
subunit (Figure 20). While the labeling by the GABABR1 antibody was generally
stronger in the periphery than the center of a cell body, the labeling by the GABABR2
antibody was typically stronger in the center than the periphery of a cell body. This was
consistent in both PS- and SS-treated animals.
A mean OD value was obtained for each cell body (See Section 2.3 for method).
The number of immunoreactive cell bodies and the distribution of OD values of
immunoreactive cell bodies were compared in six pairs of PS- and SS-treated animals.
For GABABR1 subunit, there was a significant increase in the mean OD of the SS-treated
animals in all subdivisions (two-way ANOVA; p<0.01; n=6). Compared with that of a
PS-treated animal, the distribution of the normalized OD of an SS-treated animal was
shifted rightward, indicating an increase in the level of labeling in the cell bodies of the
amygdaloidal cells (Figure 21 and Figure 22a). This change was observed in all four
subdivisions, with the largest change being in the LaN. The density of labeled cells,
measured as number per square millimeter, was also increased in the SS-treated animal
(Figure 22b). This increase was significant (two-way ANOVA; p<0.05; n=6)
The effect of SS on GABABR2-immunoreactive cell bodies was similar that on
GABABR1-immunoreactive cell bodies. The drug caused a rightward shift to the
distribution of the OD of labeled cell bodies, indicating the drug increased the level of
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Figure 21: Histograms showing the number of neurons within a specific normalized
mean OD in GABABR1 immunolabeled cells in the amygdala. Black bars represent
PS-treated animals and white bars represent SS-treated animals.
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Figure 22: Group results from IHC experiments showing changes in (A) normalized
OD values of the cells bodies in each subunit and (B) cell density of GABABR1
immunolabeled cells in the amygdala. (A) Results were normalized against the
cerebellum from the specific IHC experiment. Results were obtained from six pairs of
animals and are statistically significant (two-way ANOVA (22); p<0.01) (B) Results
were measured as cells per square millimeter. Results were obtained from six pairs of
animals and are statistically significant (two-way ANOVA (22); p<0.05).
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Figure 23: Histograms showing the number of neurons within a specific normalized
mean OD in GABABR2 immunolabeled cells in the amygdala. Black bars represent
PS-treated animals and white bars represent SS-treated animals.
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Figure 24: Group results from IHC experiments showing changes in (A) normalized
OD values of the cells bodies in each subunit and (B) cell density of GABABR2
immunolabeled cells in the amygdala. (A) Results were normalized against the
cerebellum from the specific IHC experiment. Results were obtained from six pairs of
animals and are statistically significant (two-way ANOVA (22); p<0.001). (B) Results
were measured as cells per square millimeter. Results were obtained from six pairs of
animals and are statistically significant (two-way ANOVA (22); p<0.05).
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GABABR2 subunit in all the amygdaloid subdivisions (Figure 23). The increase was the
highest in the LaN. Group results revealed a significant increase in all the mean OD of all
subdivisions (two-way ANOVA; p<0.001; n=6), along with a significant increase in the
number of labeled cells per square millimeter (two-way ANOVA; p<0.05; n=6) (Figure
24).
3.3 Effect of SS on the level of GABAB receptor subunits in the hippocampus
3.3.1 Normative immunoreactivities against GABABR1 and GABABR2 in the
hippocampus
Results from six PS-treated animals were examined to understand the normative
immunoreactivities against GABABR1 and GABABR2. For both subunits, an
immunoreactivity was observed throughout the entire structure. The subdivisions were
not found consistently throughout the structure: the SUB appeared only in caudal slices,
while all other subdivisions were found throughout the whole rostrocaudal extent. The
level of labeling was reduced from the rostral to the caudal part of the structure. A closer
examination of the subdivisions showed a similar level of labeling in CA1-CA3, DG, and
SUBd and a higher level of labeling in the SUBv. In caudal slices, the DG showed an
area difference: the dorsal portion showed a higher labeling than the ventral portion.
3.3.2 Effect of SS on the overall level of receptor subunits in the hippocampus
IHC experiments were conducted using tissues from the hippocampus in six pairs
of PS- and SS-treated animals. Overall level of labeling (i.e., all the cell bodies and
surrounding neuropil regions combined) in the entire hippocampus were quantified in
these six cases.
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Figure 25: Change in overall mean OD of SS-treated animals in the hippocampus.
(A) shows immunolabeling against GABABR1 subunit and (B) shows the
immunolabeling against the GABABR2 subunit in the cerebellum (top panel) and
hippocampus (bottom panel) in both PS- and SS-treated animals. Scale bar: 300µm.
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As shown by an example in Figure 25, there was no difference in the level of
labeling between the cerebellar sections from PS- and SS-treated animals for both
subunits (Figure 25). In contrast, a change in the level of labeling was observed in certain
areas of the hippocampus for both the GABABR1 and GABABR2 subunits (Figure 25).
The two pairs of hippocampal sections in Figure 25 show immunoreactivities against
GABABR1 and GABABR2, respectively. Each pair of sections was from a pair of PS- and
SS-treated animals at the mid portion of the rostrocaudal extent of the hippocampus.
Overall, the level of the receptor subunits was increased in the section from the SStreated animal.
The effect of SS on the level of the GABABR1 and GABABR2 subunits was
examined over the entire rostrocaudal extent of the hippocampus (Figure 26 and Figure
27). Overall, an increase in immunoreactivity against the GABABR1 subunit was
observed in caudal sections in SS-treated animals. In contrast, a reduction in
immunoreactivity against GABABR1 subunit was observed in rostral sections in SStreated animals.
The GABABR2 subunit showed a very similar spatial pattern of change to that of
change in GABABR1 throughout the rostrocaudal extent of the hippocampus (Figure 27)
Overall, an increase in the immunoreactivity against GABABR2 was observed in caudal
sections and a reduction in immunoreactivity was observed in rostral sections in SStreated animals.
For each receptor subunit, a weighted average OD was calculated for each animal
by using the measurements from all the hippocampal regions in the entire set of 12
sections (Figure 28). Group results from six pairs of PS- and SS-treated animals
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Figure 26: Immunolabeling against GABABR1 in the rostrocaudal slices of the
hippocampus. Hippocampal region is outlined. Scale bar: 300µm.

73

Figure 27: Immunolabeling against GABABR2 in the rostrocaudal slices of the
hippocampus. Hippocampal regions is outlined. Scale bar: 300µm.
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Figure 28: Group results from IHC experiments showing overall changes in
normalized OD values of the hippocampus in both GABABR1 and GABABR2
subunits. Results were combined from the OD of the major subdivisions and then
normalized the cerebellum from the specific IHC experiment. Results were obtained from
six pairs of animals and statistically significant in both GABABR1 (two-tail T-test (35);
t=3.1781; p<0.05) and GABABR2 (two-tail T-test (35); t=3.6048; p<0.05).
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Figure 29A: High magnification images of the CA1-CA3 subdivisions of the
hippocampus labeled against GABABR1. Low magnification images show the different
subdivisions for the PS and SS-treated animals. Corresponding high magnification
images are from the specific subdivisions. Low magnification image scale bar: 300µm.
High magnification image scale bar: 25µm.
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Figure 29B: High magnification images of the DG, SUBv, and SUBd subdivisions of
the hippocampus labeled against GABABR1. Low magnification images show the
different subdivisions for the PS and SS-treated animals. Corresponding high
magnification images are from the specific subdivisions. Low magnification image scale
bar: 300µm. High magnification image scale bar: 25µm.
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indicate that SS increased the level of receptor subunits in the hippocampus (Figure 28).
This increase was statistically significant in both GABABR1 (two-tail T-test; p<0.05;
n=6) and GABABR2 (two-tail T-test; p<0.05; n=6).
3.3.3 The effect of SS in major hippocampal subdivisions
Levels of immunoreactivities against the GABABR1 and GABABR2 subunits in 6
main subdivisions of the hippocampus were quantified in three cases. A weighted average
OD was obtained for each subdivision for both GABABR1 and GABABR2 subunits. For
GABABR1 the largest increase was observed in the CA1-CA2 regions. Similar changes
were observed in CA3, DG, SUBd, and SUBv (Figure 29 and Figure 31a). For the CA3
and DG subdivisions, there exist a rostrocaudal area difference in which an increase in
OD is obsereved in the caudal slices and a decrease is observed in the rostral slices.
Overall, the increase of mean OD in all subdivisons was not statistically significant (twoway ANOVA; 0.11541; n=6).
The effect of SS on GABABR2 was also quantified in six cases examining all six
subdivisions. Results indicated an increase in level of labeling in all subdivisions. Similar
increase was observed in CA2, DG, and SUBd, but larger in CA1, CA3, and SUBv
(Figure 30 and Figure 31b). Similar to the GABABR1 subunit, CA1 and DG showed an
increase in mean OD in caudal slices and a decrease in rostral slices in SS-treated
animals. Overall the increase was not statistically significant in all subdivisions (twoway ANOVA; p <0.05; n=6).
3.3.4 The effect of SS on immunoreactivities in cell bodies
Both GABABR1 and GABABR2 subunits were studied to understand the effect of
SS on the level of immunoreactivity in cellular regions in six cases. High magnification
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Figure 30A: High magnification images of the CA1-CA3 subdivisions of the
hippocampus labeled against GABABR2. Low magnification images show the different
subdivisions for the PS and SS-treated animals. Corresponding high magnification
images are from the specific subdivisions. Low magnification image scale bar: 300µm.
High magnification image scale bar: 25µm.
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Figure 30B: High magnification images of the DG, SUBv, and SUBd subdivisions of
the hippocampus labeled against GABABR2. Low magnification images show the
different subdivisions for the PS and SS-treated animals. Corresponding high
magnification images are from the specific subdivisions. Low magnification image scale
bar: 300µm. High magnification image scale bar: 25µm.
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Figure 31: Group results from IHC experiments showing overall changes in
normalized OD values of the major subdivisions of the hippocampus in both
GABABR1 and GABABR2 subunits. Results were normalized against the cerebellum
from the specific IHC experiment. Results were obtained from six pairs of animals.
Results were not statistically significant for GABABR1 (two-way ANOVA (35); 0.11541)
and statistically significant for GABABR2 (two-way ANOVA (35); p <0.05).
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Figure 32: High magnification images showing immunolabeled cells against
GABABR1 and GABABR2 in the six major subdivisions of the hippocampus. Both
PS- and SS-treated animals were labeled against GABABR1 and GABABR2 in the (A)
CA1, (B) CA2, (C) CA3, (D) DG, (E) SUBd, and (F) SUBv. Scale bar: 10µm.
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Figure 33: Histograms showing the number of neurons within a specific normalized
mean OD in GABABR1 immunolabeled cells in the hippocampus. Black bars
represent PS-treated animals and white bars represent SS-treated animals.
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images revealed a difference in the cellular distributions of the GABABR1 and
GABABR2 subunits in hippocampal cells (Figure 32). While immunoreactivity against
GABABR1 subunit was typically stronger in the surrounding area than the center of a cell
body, the immunoreactivity against the GABABR2 subunit was typically stronger in the
center then the surrounding area of a cell. This difference was observed throughout the
structures in both PS- and SS-treated animals.
In six pairs of PS- and SS-treated animals, the level of labeling was evaluated in
GABABR1-immunoreactive cell bodies in the hippocampus using mean OD values
(Figure 33). For each subdivision, there was a rightward shift in the distribution of mean
OD in an SS-treated animal, indicating an overall increase in the level of GABABR1 in
the SS-treated animals. Group results supports that the drug caused an increase in the
level of labeling in the GABABR1 subunit. The increase was highest in SUBv subdivision
(Figure 34a). This change for all subdivisions was statistically significant (two-way
ANOVA; p<0.01; n=6). Group results also indicated a tendency of increase in the
number of labeled cells per square millimeter (Figure 34b). However, this increase was
not statistically significant in all subdivisions (two-way ANOVA; p=0.22588; n=6).
Similar analysis was conducted for cell bodies showing immunoreactivities
against the GABABR2 subunit. The distribution of ODs of labeled cells was shifted
rightward in the SS-treated animal of each of the 6 pairs of animals (Figure 35). Group
results supports that the drug caused an increase in the mean OD of labeled cells in all
subdivisions of the hippocampus, with the largest change being in the SUBv (Figure 36a).
These results were statistically significant (two-way ANOVA; p<0.01; n=6). Group
results also indicated a tendency of increase in the number of labeled cell bodies per
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Figure 34: Group results from IHC experiments showing changes in (A) normalized
OD values of the cells bodies in each subunit and (B) cell density of GABABR1
immunolabeled cells in the hippocampus. (A) Results were normalized against the
cerebellum from the specific IHC experiment. Results were obtained from six pairs of
animals and were statistically significant (two-way ANOVA (35); p<0.01). (B) Results
were measured as cells per square millimeter. Results were obtained from six pairs of
animals and were not statistically significant (two-way ANOVA (35); p=0.22588).
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Figure 35: Histograms showing the number of neurons within a specific normalized
mean OD in GABABR2 immunolabeled cells in the hippocampus. Black bars
represent PS-treated animals and white bars represent SS-treated animals.
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Figure 36: Group results from IHC experiments showing changes in (A) normalized
OD values of the cells bodies in each subunit and (B) cell density of GABABR1
immunolabeled cells in the hippocampus. (A) Results were normalized against the
cerebellum from the specific IHC experiment. Results were obtained from six pairs of
animals and were statistically significant (two-way ANOVA (35); p<0.01). (B) Results
were measured as cells per square millimeter. Results were obtained from six pairs of
animals and were not statistically significant (two-way ANOVA (35); 0.08328).
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square millimeter (Figure 36b). This increase was not statistically significant (two-way
ANOVA; 0.08328; n=6).
4 Discussion
My results revealed that a systemic application of SS caused an increase in the
level of GABABR1 and GABABR2 subunits in the amygdala and the hippocampus. The
increase was generally larger in the amygdala than in the hippocampus. A regional
difference in the level of increase was seen in the amygdala. For both subunits, the
percent increase was the greatest in the LaN and smallest in the BMA. A moderate
increase was seen in the BLA and CeN. Apparent area differences existed in the
hippocampus. Overall, for GABABR1 subunit showed a larger percentage increase in the
weighted average OD of CA1-CA2 regions, whereas a moderate increase was observed in
CA3, DG, SUBd, and SUBv. The GABABR2 subunit showed a larger percentage
increase in the weighted average OD of CA1, CA3, and SUBv, whereas a moderate
increase was observed in the CA2, DG, and SUBd.
4.1 Technical considerations
Both positive and negative control experiments were conducted to ensure the
effectiveness of experimental procedures and reliability of results from the limbic
structures (Figure 11). Each of the immunohistochemical experiments done to probe
GABABR1 or GABABR2 subunit in a pair of PS- and SS-treated animals consisted of a
pair of cerebellar sections from the same pair of animals. While the experiments revealed
an increase in the level of immunolabeling in the limbic structures, they did not reveal a
change in the cerebellum. This indicates that changes in the level of GABABR1 and
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GABABR2 subunits observed in the limbic structures were due to the drug and not other
possible factors.
An SS injection of 250mg/kg was used to reliably induce tinnitus in the SS-treated
animals. This amount is relatively high in comparison to the amount humans are regularly
exposed to. Therefore, a direct comparison of tinnitus between humans and experimental
animals cannot be made. The amount was used to ensure that tinnitus had been subjected
in the animals, so that neurochemical changes could be studied. Understanding of such
changes can lead to possible future treatments.
The current study examined GABABR1 and GABABR2 subunits separately.
Results can’t be used to make a definite conclusion about the effect of SS on functional
GABAB receptors. However, parallel changes in the level of immunoreactivity between
the two receptor subunits strongly suggest that the level of functional GABAB receptors
were changed by the drug. Existing results indicate that GABABR1 is synthesized in the
endoplasmic reticulum and contains a retention signal that does not allow it to travel to
the plasma membrane. GABABR2 is required to bind to the GABABR1 subunit, which
leads to masking of the retention signal and consequently a functional GABAB receptor
can be formed in the plasma membrane (Pin et al., 2004). Immunofluorescent double
labeling experiments should be conducted to make a definite conclusion regarding the
effect of SS on the level functional GABAB receptors in limbic structures.
4.2 Possible neurophysiological consequences of an increase in the level of
GABABR1 and GABABR2
An increase in the level of GABAB receptors can lead to different
neurophysiological consequences depending on whether these receptors are distributed
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pre- or postsynaptically. Upon activation of postsynaptic GABAB receptors a prolonged
inhibition occurs. After GABA binds to the receptor, it leads to the dissociation of the βγsubunit from the α-subunit in the G-protein. This subunit activates GIRK, which is
activated and allowed K+ to leave the cell, thereby hyperpolarizing the cell membrane
(Luscher et al., 1997; Ulrich and Bettler, 2007). By increasing the level of postsynaptic
GABAB receptors, it is possible to decrease the neural activity due to an increase in
inhibitory neurotransmission.
Presynaptic GABAB receptors function by inhibiting the release of GABA or
glutamate neurotransmitters (Ma et al., 2002; Kornau, 2006). Upon GABA binding, the
βγ-subunit dissociates from the α-subunit. It leads to the modification of voltage-gated
Ca2+ channels. This causes a reduction in Ca2+ influx, which leads to a decrease in
neurotransmitter release (Herlitze et al., 1996; Ikeda, 1996). By increasing the level of
presynaptic GABAB receptors, there is possibility of either an increase or decrease in
neural activity depending on which neurotransmitter is regulated. Regulation of glutamate
can lead to a decrease in neural activity as this means a reduction in excitatory
neurotransmission. Regulation of GABA can lead to an increase in neural activity as this
means a reduction in inhibitory neurotransmission.
4.3 The effect of SS on the amygdala and hippocampus
4.3.1 Neural activity vs. the level of GABAB receptors
Previous studies have indicated that SS can lead to an increase in neural activity
in the amygdala and hippocampus (Chen et al., 2014). The present study focused on
neurochemical changes following a systemic application of SS and revealed an increase
in the level of GABAB receptors in the amygdala and hippocampus. It is highly likely that
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it was presynaptic GABAB receptors that were increased in the present study. Such
presynaptic GABAB receptors serve as auto-receptors and regulate the release of GABA.
This regulation can certainly enhance neural responses as revealed by the previous
physiological study conducted by Chen and colleagues. It should be noted that
GABAergic auto-receptors have been found in both the amygdala and hippocampus
(Yamada et al., 1999; Ariwodola and Weiner, 2004).
4.3.2 Area dependence in the change of level of GABAB receptors
The amygdala showed a larger change in the level of GABAB receptors than the
hippocampus. There is a logical explanations for such findings. The amygdala has direct
connections from the auditory structures, i.e. projections from the MGN, whereas the
hippocampus is indirectly connected to the auditory structures by projections to and from
the amygdala (Kraus and Canlon, 2012). The MGN sends direct projections to the LaN of
the amygdala (Graybiel, 1972; Aitkin, 1986) and the AC sends indirect projections to the
LaN (Kraus and Canlon, 2012). The LaN then sends projections to the BLA, which
sends direct projections to the CA1, CA3 and indirect connections to the SUB (Kraus and
Canlon, 2012).
Projections towards the auditory system include the CA1 and SUB, which send
projections to the LaN, BMA, and BLA. The BLA then sends direct projections to the IC
in the auditory pathway (Sah et al., 2003; LeDoux, 2007; Kraus and Canlon, 2012).
The current study found an area difference in which the largest increase in
GABAB receptors was found in the LaN in the amygdala and the SUBv in the
hippocampus. The involvement of LaN and SUBv in receiving and sending information
from/to the CAS, respectively, is quite important. LaN receives projections from the
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MGN, while SUB sends information towards the amygdala to relay it back to the CAS
(Kraus and Canlon, 2012). However, further studies are required to understand the neural
activity in each subdivision and how it relates to GABAB receptors. This would allow to
further speculating as to what activity changes would be caused in the CAS due to limbic
structures.
4.4. Effects of SS on the level of GABAB receptors in limbic structures vs. major
auditory structures
Previous studies have indicated that systemic application causes a change in
neural activity in both the central auditory system (House and Brackman, 1981; Barrs and
Brackman, 1984; Berliner et al., 1992; Kaltenbach et al., 2005) and the limbic system
(Mahlke and Wallhausser-Franke, 2004; Gong et al., 2008; Chen et al., 2014).
Specifically, both these systems show an increase in neural activity following the
application of the drug.
A neurochemical study (Butt et al., 2016) revealed that SS reduced the level of
GABAB receptors in an auditory structure, the IC. In contrast, the present study found
that the drug caused an increase in the level of GABAB receptors in limbic structures.
Therefore, a seeming discrepancy exists between the drug effects on the level of GABAB
receptors in the IC and limbic structures, inspte of similar increases in the physiological
activity in these structures.
It is speculated that in the IC SS reduced postsynaptic GABAB receptors and/or
presynaptic GABAB receptors on glutamatergic axon terminals. A reduction in these
GABAB receptors would enhance the release of glutamate from presynaptic terminal or
reduce the inhibitory postsynaptic potentials mediated by the postsynaptic GABAergic
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neurons. Consequently, this could enhance the overall activity in the IC. In the limbic
structures, it is possible that the drug increase presynaptic GABAB receptors on
GABAergic axon terminals. Such an increase could reduce the release of GABA, leading
to a decrease in inhibition and an increase in activity.
4.5 SS-induced change in the level of GABAB receptors: Implications for higher
brain functions
4.5.1 Tinnitus
SS-induced tinnitus leads to changes in neural activity in the limbic structures
(Chen et al., 2012) as well as central auditory structures (; House and Brackman, 1981;
Barrs and Brackman, 1984; Berliner et al., 1992). Previous studies have suggested that SS
can affect neurotransmitter receptors and ion channels (Basta et al., 2000; Basta and
Ernst, 2004). The present study viewed the neurochemical changes in GABAB receptors
caused by SS in limbic structures. The drug showed to cause an increase in the GABAB
receptors, which can lead to a change in neural activity, thereby tipping the balance of
excitation and inhibition in the limbic structures.
Previous studies have found an increase in neural activity in the limbic structures
following SS-induced tinnitus (Chen et al., 2012). It is not fully understood what changes
could cause this gain. The present study showed an increase in the level of GABAB
receptors in both the amygdala and hippocampus. The increase in activity can be due to
the increase in GABAB receptors, specifically presynaptic GABAB receptors (see section
4.2 for details).
The limbic structures are connected to CAS, forming a neural circuit. The CAS
forms a neural circuit as well in which they are also connected to each other. Change in
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neural activity in one structure an affect others found in the neural circuit. Hyperactivity
in the limbic structures can cause an enhancement in the CAS. It is likely that such an
increase can lead to an enhanced synchronization and an epileptic form of firing
responses. Such responses can be speculated to be responsible for tinnitus sensation.
4.5.2 Other functions (e.g., emotion, memory etc.)
The main roles of the amygdala and hippocampus are in emotion and memory,
respectively. Regulation of neural activity is required throughout the CNS for appropriate
higher order functioning (Gerken et al., 1984; Bauer et al., 1999). Therefore, it is highly
possible that SS-induced tinnitus can affect these functions. An enhanced level of
GABAB receptors as observed in the present study can lead to a change in neural activity
and consequently a change in higher order functions.
A study found strong correlations between tinnitus and stress, anxiety, and
depression. Individuals with tinnitus have reported to be stressed due to the condition
(Langguth, 2011). More research is required on understanding how memory is affected
due to tinnitus. It is highly probable that there may be a decrease in memory formation.
Many subjects that report tinnitus, explain a hard time concentrating. Since concentration
is required during memory formation, it may become more difficult and require a longer
period of time for those with chronic tinnitus to consolidate their memory.
Not much evidence exists for the changes tinnitus can cause to emotion and
memory. Future research should focus on how SS can affect these functions.
Understanding this can lead to possible clinical methods designed to help patients battling
with emotional distress or who have trouble forming memories.
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4.6 Possible cellular mechanisms underlying changes in the level of the GABAB
receptors
As noted in this study, there was an increase in the level of GABAB receptors,
following a systemic application of SS. Many proteins are required to allow this increase
to happen. Previous studies have examined other proteins and their changes to proteins
due to SS-induced tinnitus. In the amygdala, two immediate early genes were studied:
arg3.1 and c-fos (Mahlke and Wallhausser-Franke, 2004). Following SS-induced tinnitus,
the genes showed an increase in expression. These genes are required in many biological
functions and its possible that they aid in synthesis of GABA/GABAB receptors. In
another study, an increase in GAD1 levels was observed in the hippocampus after SSadministration (Im et al., 2007). The enzyme GAD1 is required to synthesize GABA;
therefore an increase in GAD1 is an indirect indication of an increase in GABA. An
increase in the neurotransmitter could indicate that it is upregulated because it is required
to bind functional GABAB receptors.
4.7 Conclusions and Future directions
A systemic application of SS can lead to an increase in the level of GABABR1
and GABABR2 subunits in the amygdala and hippocampus three hours later. The drug
causes a larger change in the amygdala than the hippocampus. These findings can help us
understand the induction/manifestation of SS-induced tinnitus. Furthermore, they
strongly suggest that further research should be conducted to examine how SS can cause
changes in other functions of the brain such as emotion and memory.
The current study focused on how SS changed the level of GABABR1 and
GABABR2 subunits. Further experiments should be conducted by using techniques such
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as immunofluorescence double labeling and ligand binding. Double labeling can give
insight to if the two receptor subunits are co-localized and forming heterodimers, which
can give a firm conclusion about SS changes the level of functional receptors. Ligand
binding can also be used to examine the effect of SS on functional receptors in the limbic
structures.
Other experiments should be conducted to examine whether SS primarily affect
pre- or postsynaptic GABAB receptors. From the current study it was inferred that the
drug-induced increase maybe due to presynaptic auto-receptors. To confirm these
findings, experiments should be designed to label both GABAB receptors and other preor postsynaptic proteins in PS- and SS-treated animals. In this way, a more definite
answer as to whether pre- or postsynaptic GABAB receptors are mainly affected by a
systemic application of SS can be obtained. Furthermore, patch-clamp recordings can be
used to examine whether blocking of GABAB receptors leads to the change in the
neurotransmitter release in PS- and SS-treated animals. All the experiments described
above will all help enhance our understanding of the effect of SS on the level and
function of the GABAB receptor in limbic structures.
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TABLES
Table 1: Summary results of OD values of the molecular layer of the cerebellum.
GABABR1
39.83
47.33

PS-treated
SS-treated

GABABR2
40.33
50.00

Table 2: Summary results of normalized OD values of overall changes in the amygdala
GABABR1
0.3136
0.5456

PS-treated
SS-treated

GABABR2
0.2762
0.4756

Table 3: Summary results of normalized OD values of overall changes in the major
subdivisions of the amygdala labeled against GABABR1
PS-treated
SS-treated

BLA
0.2733
0.5159

BMA
0.3982
0.5238

CeN
0.3412
0.6314

LaN
0.2418
0.5112

Table 4: Summary results of normalized OD values of overall changes in the major
subdivisions of the amygdala labeled against GABABR2
PS-treated
SS-treated

BLA
0.2907
0.4698

BMA
0.3272
0.5005

CeN
0.2325
0.4149
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LaN
0.2543
0.5171

Table 5: Summary results of normalized OD values of cell bodies in the major
subdivisions of the amygdala labeled against GABABR1
PS-treated
SS-treated

BLA
0.8167
1.0917

BMA
0.9500
1.1833

CeN
0.9500
1.2700

LaN
0.7250
1.0167

Table 6: Summary results of cell density (in cell bodies per square millimeter) in the
major subdivisions of the amygdala labeled against GABABR1
PS-treated
SS-treated

BLA
25
36

BMA
41
46

CeN
43
51

LaN
36
38

Table 7: Summary results of normalized OD values of cell bodies in the major
subdivisions of the amygdala labeled against GABABR2
PS-treated
SS-treated

BLA
0.8667
1.3500

BMA
0.9750
1.4417

CeN
0.7700
1.2800

LaN
0.7500
1.2100

Table 8: Summary results of cell density (in cell bodies per square millimeter) in the
major subdivisions of the amygdala labeled against GABABR2
PS-treated
SS-treated

BLA
38
46

BMA
38
45

CeN
48
57
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LaN
34
48

Table 9: Summary results of normalized OD values of overall changes in the
hippocampus
GABABR1
0.3768
0.4555

PS-treated
SS-treated

GABABR2
0.4976
0.5977

Table 10: Summary results of normalized OD values of overall changes in the major
subdivisions of the amygdala labeled against GABABR1
PS-treated
SS-treated

CA1
0.3516
0.4697

CA2
0.4090
0.5483

CA3
0.4312
0.5026

DG
0.3520
0.3842

SUBd
0.2975
0.3743

SUBv
0.4195
0.4540

Table 11: Summary results of normalized OD values of overall changes in the major
subdivisions of the amygdala labeled against GABABR2
PS-treated
SS-treated

CA1
0.4741
0.5958

CA2
0.5717
0.6248

CA3
0.4892
0.6049

DG
0.4567
0.5447

SUBd
0.4386
0.5235

SUBv
0.5551
0.6925

Table 12: Summary results of normalized OD values of cell bodies in the major
subdivisions of the amygdala labeled against GABABR1
PS-treated
SS-treated

CA1
0.9750
1.1750

CA2
0.9517
1.1417

CA3
1.0200
1.2500
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DG
1.0333
1.2333

SUBd
0.9083
1.1167

SUBv
0.9500
1.2000

Table 13: Summary results of cell density (in cell bodies per square millimeter) in the
major subdivisions of the amygdala labeled against GABABR1
PS-treated
SS-treated

CA1
28
33

CA2
58
71

CA3
44
44

DG
19
21

SUBd
38
47

SUBv
40
39

Table 14: Summary results of normalized OD values of cell bodies in the major
subdivisions of the amygdala labeled against GABABR2
PS-treated
SS-treated

CA1
1.10
1.42

CA2
1.11
1.43

CA3
1.16
1.53

DG
1.08
1.41

SUBd
1.04
1.43

SUBv
1.15
1.55

Table 15: Summary results of cell density (in cell bodies per square millimeter) in the
major subdivisons of the amygdala labeled against GABABR2
PS-treated
SS-treated

CA1
27
29

CA2
42
53

CA3
36
43
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DG
32
34

SUBd
46
46

SUBv
42
44
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APPENDICES
Solutions needed for immunohistochemistry experiments:
0.5M Sodium Phosphate Dibasic
For 1L:
70.98g sodium phosphate dibasic powder (NaH2PO4H2O)
1L of diH2O
0.5M Sodium Phosphate Monobasic
For 1L:
68.99g anahydrous sodium phosphate monobasic (NaH2PO4)
1L diH2O
0.4M Sodium Phosphate Buffer (PB) (pH=7.2)
For 1L:
600mL 0.5M sodium dibasic solution
200mL 0.5M sodium phosphate monobasic solution
200mL diH2O
0.1M Sodium Phosphate Buffer (PB) (pH=7.2)
For 1L:
250mL 0.4M PB
750mL diH2O
0.1M Phosphate Buffer Saline (PBS) (pH=7.2)
For 1L:
250mL 0.4M PB
750mL diH2O
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4% Paraformaldehyde (PFA) in 0.1PB (pH=7.2)
For 1L:
40g PFA powder
1L 0.1M PB
PFA can be dissolved into the PB by heating on a stir plate at a low heat
setting. pH can be adjusted by adding HCl or NaOH.
Cyroprotectant solution
For 100mL:
30g sucrose
100mL PB
0.05% Triton in 0.1M PBS (TPBS)
For 1L:
0.05mL Triton X-100
1L 0.1M PBS
3,3’ diaminobenzidine tetrahydrochloride (DAB)-nickel solution
For 20mL:
5mL 0.4M PB
200µL 0.4% NH4Cl in 0.1M PB
200µL glucose
13.6mL diH2O
200µL 50mg/ml DAB in 0.1M PB
0.8mL 1% Nickel sulfate in diH2O
20µL glucose oxidase
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